| 1 | R lipoic acid | [1]  Lipoic acid Lipoic acid | - | - | - | [1]  13 13 💬
 | 
| 2 | R(+) pramipexole dihydrochloride monohydrate | [1]  Pramipexole Pramipexole | [1]  Pramipexole 
                
                    Pramipexole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  2 2 💬
 | 
| 3 | R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride | [1]  Benzofuran Benzofuran | - | - | - | [1]  6 6 💬
 | 
| 4 | R-021 | - | - | - | - | [1]  222 222 💬
 | 
| 5 | R-3750 | - | - | - | - | [1]  97 97 💬
 | 
| 6 | R-ATG | - | - | - | - | [1]  60 60 💬
 | 
| 7 | R-Gene | [1]  Arginine Arginine | [1]  Arginine 
                
                    Arginine
                
             💬
 | - | - | [1]  78 78 💬
 | 
| 8 | R-Gene 10 | [1]  Arginine Arginine | [1]  Arginine 
                
                    Arginine
                
             💬
 | - | - | [1]  78 78 💬
 | 
| 9 | R-hGH | - | - | - | - | [1]  78 78 💬
 | 
| 10 | R-hGH freeze-dried | - | - | - | - | [1]  78 78 💬
 | 
| 11 | R-hGH liquid (Saizen) | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 12 | R-hIL-18BP | - | - | - | - | [1]  65 65 💬
 | 
| 13 | R-metHuGDNF | [1]  Liatermin Liatermin | [1]  Liatermin 
                
                    Liatermin
                
             💬
 | - | - | [1]  6 6 💬
 | 
| 14 | R-metHuLeptin | [1]  Metreleptin Metreleptin | [1]  Metreleptin 
                
                    Metreleptin
                
             💬
 | [1]  LEPR LEPR 💬
 | [6]  AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬 | [1]  265 265 💬
 | 
| 15 | R-roscovitine | [1]  Seliciclib Seliciclib | - | - | - | [1]  75 75 💬
 | 
| 16 | R-salbutamol | [2]  Levosalbutamol Levosalbutamol, Salbutamol | [2]  Albuterol 
                
                    Albuterol
                
            , 
                
                    Levosalbutamol
                
             💬
 | [1]  ADRB2 ADRB2 💬
 | [9]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1]  49 49 💬
 | 
| 17 | R-salbutamol sulphate | [2]  Levosalbutamol Levosalbutamol, Salbutamol | [2]  Albuterol 
                
                    Albuterol
                
            , 
                
                    Levosalbutamol
                
             💬
 | [1]  ADRB2 ADRB2 💬
 | [9]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1]  49 49 💬
 | 
| 18 | R03AC02 | - | - | - | - | [1]  299 299 💬
 | 
| 19 | R03CC02 | - | - | - | - | [1]  299 299 💬
 | 
| 20 | R05C B01 | - | - | - | - | [1]  299 299 💬
 | 
| 21 | R05CB01 | - | - | - | - | [1]  193 193 💬
 | 
| 22 | R3R01 | - | - | - | - | [2]  218 218, 222 💬
 | 
| 23 | R727 | - | - | - | - | [1]  79 79 💬
 | 
| 24 | R788 | - | - | - | - | [2]  46 46, 63 💬
 | 
| 25 | R788 sodium hexahydrate, RIG2-01, RIG-G | - | - | - | - | [1]  46 46 💬
 | 
| 26 | R788 Sodium, R788 Na, R788 | - | - | - | - | [1]  46 46 💬
 | 
| 27 | R788, fostamatinib disodium hexahydrate (in USPI/FPI) | [1]  Fostamatinib Fostamatinib | [1]  Fostamatinib 
                
                    Fostamatinib
                
             💬
 | [1]  SYK SYK 💬
 | [17]  B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | [1]  61 61 💬
 | 
| 28 | R932333 | - | - | - | - | [1]  49 49 💬
 | 
| 29 | R935788 | - | - | - | - | [3]  46 46, 61, 66 💬
 | 
| 30 | RA101495 | - | - | - | - | [1]  62 62 💬
 | 
| 31 | RA101495 sodium | - | - | - | - | [1]  62 62 💬
 | 
| 32 | RA15804589, C19061501-F, DNL788, DN2489, DN0002489 | - | - | - | - | [2]  2 2, 13 💬
 | 
| 33 | RAAV 2/6 hIDS DONOR | - | - | - | - | [1]  19 19 💬
 | 
| 34 | RAAV-GAD | - | - | - | - | [1]  6 6 💬
 | 
| 35 | RAAV-Olig001-ASPA | [1]  MYR-101 MYR-101 | - | - | - | [1]  307 307 💬
 | 
| 36 | RAAV.hPDE6A vector | - | - | - | - | [1]  90 90 💬
 | 
| 37 | RAAV1-CB-hAAT | - | - | - | - | [1]  231 231 💬
 | 
| 38 | RAAV1-CMV-GAA (study agent) Administration | - | - | - | - | [1]  256 256 💬
 | 
| 39 | RAAV1.CMV.huFollistatin344 | - | - | - | - | [2]  15 15, 113 💬
 | 
| 40 | RAAV1.CMV.huFollistin344 | - | - | - | - | [1]  113 113 💬
 | 
| 41 | RAAV1.tMCK.human-alpha-sarcoglycan- First cohort | - | - | - | - | [1]  113 113 💬
 | 
| 42 | RAAV1.tMCK.human-alpha-sarcoglycan- Second cohort | - | - | - | - | [1]  113 113 💬
 | 
| 43 | RAAV2-CB-hAAT Gene Vector | - | - | - | - | [1]  231 231 💬
 | 
| 44 | RAAV2-ND4 | - | - | - | - | [1]  302 302 💬
 | 
| 45 | RAAV2.5-CMV-minidystrophin (d3990) | - | - | - | - | [1]  113 113 💬
 | 
| 46 | RAAV2/2-ND4 VECTOR | - | - | - | - | [1]  302 302 💬
 | 
| 47 | RAAV2/5-hNAGLU | - | - | - | - | [1]  19 19 💬
 | 
| 48 | RAAV2/5-PBGD vector dosage 1 | - | - | - | - | [1]  254 254 💬
 | 
| 49 | RAAV2/5-PBGD vector dosage 2 | - | - | - | - | [1]  254 254 💬
 | 
| 50 | RAAV2/5-PBGD vector dosage 3 | - | - | - | - | [1]  254 254 💬
 | 
| 51 | RAAV2/5-PBGD vector dosage 4 | - | - | - | - | [1]  254 254 💬
 | 
| 52 | RAAV2/6 Left ZFN Vector | - | - | - | - | [1]  19 19 💬
 | 
| 53 | RAAV2/6 Right ZFN Vector | - | - | - | - | [1]  19 19 💬
 | 
| 54 | RAAV2tYF-GRK1-hRPGRco | - | - | - | - | [1]  90 90 💬
 | 
| 55 | RAAV2tYF-GRK1-RPGR | - | - | - | - | [1]  90 90 💬
 | 
| 56 | RAAV5-miHTT | [1]  AMT-130 AMT-130 | - | - | - | [1]  8 8 💬
 | 
| 57 | RAAV8-Des-hMTM1 | - | - | - | - | [1]  111 111 💬
 | 
| 58 | RAAV8-hMD1 | - | - | - | - | [1]  113 113 💬
 | 
| 59 | RAAV9-CB6-AspA | - | - | - | - | [1]  307 307 💬
 | 
| 60 | RAAV9-CK8-h-µD5 | [1]  Zildistrogene varoparvovec Zildistrogene varoparvovec | - | - | - | [1]  113 113 💬
 | 
| 61 | RAAV9-hFKRPco_miR-208a | - | - | - | - | [1]  113 113 💬
 | 
| 62 | RAAV9.CMV.hNAGLU | - | - | - | - | [1]  19 19 💬
 | 
| 63 | RAAVrh74.MCK.GALGT2 | - | - | - | - | [1]  113 113 💬
 | 
| 64 | RAAVrh74.MCK.micro-Dystrophin | - | - | - | - | [1]  113 113 💬
 | 
| 65 | Rabbit | [1]  Rabbit Rabbit | - | - | - | [8]  11 11, 13, 49, 51, 60, 65, 96, 285 💬
 | 
| 66 | Rabbit anti-human thymocyte immunoglobulin | [2]  Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [2]  13 13, 96 💬
 | 
| 67 | Rabbit anti-thymocyte globulin | [1]  Rabbit Rabbit | - | - | - | [1]  65 65 💬
 | 
| 68 | Rabbit anti-thymocyte globulin (ATG) | [1]  Rabbit Rabbit | - | - | - | [1]  60 60 💬
 | 
| 69 | Rabbit anti-thymocyte globulin (r-ATG) | [1]  Rabbit Rabbit | - | - | - | [1]  60 60 💬
 | 
| 70 | Rabbit Anti-Thymoglobulin (rATG) | [2]  Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [1]  285 285 💬
 | 
| 71 | Rabbit antithymocyte globulin | [2]  Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [3]  49 49, 60, 96 💬
 | 
| 72 | Rabbit antithymoglobulin (ATG) | [1]  Rabbit Rabbit | - | - | - | [1]  60 60 💬
 | 
| 73 | Rabbit ATG | [2]  Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [2]  60 60, 285 💬
 | 
| 74 | Rabbit ATG, (Genzyme) | [2]  Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [1]  60 60 💬
 | 
| 75 | Rabbit ATG, Cyclosporine, Levamisole | [4]  Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Cyclosporine, Levamisole, Rabbit | [2]  Cyclosporine 
                
                    Cyclosporine
                
            , 
                
                    Levamisole
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1]  60 60 💬
 | 
| 76 | Rabbit ATG, Thymoglobuline (Genzyme) | [2]  Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [1]  60 60 💬
 | 
| 77 | RABBIT HUMAN T LYMPHOCYTE IMMUNOGLOBULIN | [1]  Rabbit Rabbit | - | - | - | [2]  13 13, 60 💬
 | 
| 78 | Rabeprazole | [1]  Rabeprazole Rabeprazole | [1]  Rabeprazole 
                
                    Rabeprazole
                
             💬
 | [2]  ATP4A ATP4A, ATP4B 💬
 | [4]  Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [2]  2 2, 51 💬
 | 
| 79 | Raclopride | [1]  Raclopride Raclopride | - | - | - | [4]  5 5, 6, 7, 17 💬
 | 
| 80 | Racol | - | - | - | - | [3]  6 6, 96, 291 💬
 | 
| 81 | RAD001 | - | - | - | - | [6]  34 34, 67, 89, 96, 158, 228 💬
 | 
| 82 | RAD001 1mg | - | - | - | - | [1]  158 158 💬
 | 
| 83 | RAD001 2,5 mg | - | - | - | - | [1]  158 158 💬
 | 
| 84 | RAD001 5mg | - | - | - | - | [2]  89 89, 158 💬
 | 
| 85 | RAD001 round tablets | - | - | - | - | [1]  158 158 💬
 | 
| 86 | RAD001, everolimus | [1]  Everolimus Everolimus | [1]  Everolimus 
                
                    Everolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1]  34 34 💬
 | 
| 87 | RAD001: Everolimus | [1]  Everolimus Everolimus | [1]  Everolimus 
                
                    Everolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1]  34 34 💬
 | 
| 88 | RAD011 | - | - | - | - | [1]  193 193 💬
 | 
| 89 | RADAMTS-13 | - | - | - | - | [1]  64 64 💬
 | 
| 90 | Radiofrequency | - | - | - | - | [1]  46 46 💬
 | 
| 91 | Radiographic Evaluation | - | - | - | - | [1]  34 34 💬
 | 
| 92 | Radiolabelled OligoG CF-5/20 6% Solution | - | - | - | - | [1]  299 299 💬
 | 
| 93 | Radiolabelled OligoG CF-5/20 6% Solution for Nebulisation | - | - | - | - | [1]  299 299 💬
 | 
| 94 | Radiolabelled OligoG CF-5/20 DPI | - | - | - | - | [1]  299 299 💬
 | 
| 95 | Radiolabelled OligoG CF-5/20 Dry Powder for Inhalation (DPI) | - | - | - | - | [1]  299 299 💬
 | 
| 96 | Radiopharmaceuticals | - | - | - | - | [1]  5 5 💬
 | 
| 97 | Radiprodil | [1]  Radiprodil Radiprodil | - | - | - | [1]  145 145 💬
 | 
| 98 | Radotinib | [1]  Radotinib Radotinib | - | - | - | [1]  6 6 💬
 | 
| 99 | Radotinib HCl 50 mg | [1]  Radotinib Radotinib | - | - | - | [1]  6 6 💬
 | 
| 100 | RAG1 LV CD34+ cells | - | - | - | - | [1]  65 65 💬
 | 
| 101 | RAHF | [1]  Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1]  288 288 💬
 | 
| 102 | Ralenova | - | - | - | - | [1]  13 13 💬
 | 
| 103 | RALINEPAG | [1]  Ralinepag Ralinepag | [1]  Ralinepag 
                
                    Ralinepag
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1]  86 86 💬
 | 
| 104 | Raloxifene | [1]  Raloxifene Raloxifene | [1]  Raloxifene 
                
                    Raloxifene
                
             💬
 | [2]  ESR1 ESR1, ESR2 💬
 | [10]  Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1]  46 46 💬
 | 
| 105 | Raloxifene hydrochloride | [1]  Raloxifene Raloxifene | [1]  Raloxifene 
                
                    Raloxifene
                
             💬
 | [2]  ESR1 ESR1, ESR2 💬
 | [10]  Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | [1]  46 46 💬
 | 
| 106 | Raltegravir | [1]  Raltegravir Raltegravir | [1]  Raltegravir 
                
                    Raltegravir
                
             💬
 | - | - | [4]  13 13, 26, 93, 265 💬
 | 
| 107 | Raltegravir and Zidovudine | [2]  Raltegravir Raltegravir, Zidovudine | [2]  Zidovudine 
                
                    Zidovudine
                
            , 
                
                    Raltegravir
                
             💬
 | - | - | [1]  26 26 💬
 | 
| 108 | Ramatroban | [1]  Ramatroban Ramatroban | [1]  Ramatroban 
                
                    Ramatroban
                
             💬
 | [2]  PTGDR PTGDR, TBXA2R 💬
 | [3]  Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬 | [1]  13 13 💬
 | 
| 109 | Ramelteon | [1]  Ramelteon Ramelteon | [1]  Ramelteon 
                
                    Ramelteon
                
             💬
 | [2]  MTNR1A MTNR1A, MTNR1B 💬
 | [2]  Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [3]  6 6, 8, 46 💬
 | 
| 110 | Ramipril | [1]  Ramipril Ramipril | [1]  Ramipril 
                
                    Ramipril
                
             💬
 | [1]  ACE ACE 💬
 | [6]  Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [7]  46 46, 49, 66, 67, 113, 218, 257 💬
 | 
| 111 | RANEXA | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [1]  58 58 💬
 | 
| 112 | RANEXA - 750 MG - COMPRESSA A RILASCIO PROLUNGATO- USO ORALE - BLISTER (PVC/PVDC/ALLUMINIO) 60 COMPRESSE | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [1]  58 58 💬
 | 
| 113 | RANEXA*60CPR 500MG R.P. | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [1]  58 58 💬
 | 
| 114 | RANEXA*60CPR 750MG R.P. | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [1]  58 58 💬
 | 
| 115 | Ranibizumab | [1]  Ranibizumab Ranibizumab | [1]  Ranibizumab 
                
                    Ranibizumab
                
             💬
 | [1]  VEGFA VEGFA 💬
 | [24]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [4]  34 34, 166, 227, 301 💬
 | 
| 116 | Ranibizumab injection (0.5 mg) | [1]  Ranibizumab Ranibizumab | [1]  Ranibizumab 
                
                    Ranibizumab
                
             💬
 | [1]  VEGFA VEGFA 💬
 | [24]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [2]  166 166, 301 💬
 | 
| 117 | Ranitidine | [1]  Ranitidine Ranitidine | [1]  Ranitidine 
                
                    Ranitidine
                
             💬
 | [1]  HRH2 HRH2 💬
 | [3]  Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | [2]  13 13, 65 💬
 | 
| 118 | RANKL/OPG ratio | - | - | - | - | [1]  49 49 💬
 | 
| 119 | Ranolazina | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [1]  58 58 💬
 | 
| 120 | Ranolazina Ranexa | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [1]  58 58 💬
 | 
| 121 | Ranolazine | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [6]  2 2, 58, 86, 96, 113, 114 💬
 | 
| 122 | Ranolazine 1000 MG | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [1]  2 2 💬
 | 
| 123 | Ranolazine 1000 mg PR tablets | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [1]  58 58 💬
 | 
| 124 | Ranolazine 500 MG | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [1]  2 2 💬
 | 
| 125 | Ranolazine 500 mg PR tablets | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [1]  58 58 💬
 | 
| 126 | Ranolazine 750 mg PR tablets | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [1]  58 58 💬
 | 
| 127 | Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die | [1]  Ranolazine Ranolazine | [1]  Ranolazine 
                
                    Ranolazine
                
             💬
 | - | - | [1]  58 58 💬
 | 
| 128 | RAPA-501 Autologous T cells | - | - | - | - | [1]  2 2 💬
 | 
| 129 | Rapamicina tópica al 1% y excipiente | - | - | - | - | [1]  157 157 💬
 | 
| 130 | Rapamune | [1]  Sirolimus Sirolimus | [1]  Sirolimus 
                
                    Sirolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [8]  2 2, 60, 66, 67, 84, 158, 278, 280 💬
 | 
| 131 | RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE | [1]  Sirolimus Sirolimus | [1]  Sirolimus 
                
                    Sirolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1]  2 2 💬
 | 
| 132 | RAPAMUNE 1 mg/ml oral solution | [1]  Sirolimus Sirolimus | [1]  Sirolimus 
                
                    Sirolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1]  158 158 💬
 | 
| 133 | Rapamune 1 mg/ml solución oral | [1]  Sirolimus Sirolimus | [1]  Sirolimus 
                
                    Sirolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1]  158 158 💬
 | 
| 134 | Rapamune 1mg tablets | [1]  Sirolimus Sirolimus | [1]  Sirolimus 
                
                    Sirolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1]  67 67 💬
 | 
| 135 | RAPAMUNE*100CPR RIV 1MG | [1]  Sirolimus Sirolimus | [1]  Sirolimus 
                
                    Sirolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1]  67 67 💬
 | 
| 136 | RAPAMUNE*30CPR RIV 1MG | [1]  Sirolimus Sirolimus | [1]  Sirolimus 
                
                    Sirolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1]  67 67 💬
 | 
| 137 | RAPAMUNE*30CPR RIV 2MG | [1]  Sirolimus Sirolimus | [1]  Sirolimus 
                
                    Sirolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1]  67 67 💬
 | 
| 138 | Rapamycin | [1]  Sirolimus Sirolimus | [1]  Sirolimus 
                
                    Sirolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [18]  15 15, 34, 35, 46, 49, 51, 53, 60, 61, 67, 86, 89, 96, 157, 158, 193, 256, 279 💬
 | 
| 139 | Rapamycin cream, topical, 0.5%, 1.0% w/w | [1]  Sirolimus Sirolimus | [1]  Sirolimus 
                
                    Sirolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1]  158 158 💬
 | 
| 140 | Rapamycin, sirolimus | [1]  Sirolimus Sirolimus | [1]  Sirolimus 
                
                    Sirolimus
                
             💬
 | [1]  MTOR MTOR 💬
 | [51]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2]  89 89, 158 💬
 | 
| 141 | Rapamycin-calcitriol combination | [2]  Calcitriol Calcitriol, Sirolimus | [2]  Calcitriol 
                
                    Calcitriol
                
            , 
                
                    Sirolimus
                
             💬
 | [2]  MTOR MTOR, VDR 💬
 | [55]  AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Mineral absorption, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Tuberculosis, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1]  158 158 💬
 | 
| 142 | Rapeglinide | - | - | - | - | [1]  299 299 💬
 | 
| 143 | Rapid Dose Titration Group of Subcutaneous Treprostinil | [1]  Treprostinil Treprostinil | [1]  Treprostinil 
                
                    Treprostinil
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1]  86 86 💬
 | 
| 144 | Raptiva | [1]  Efalizumab Efalizumab | [1]  Efalizumab 
                
                    Efalizumab
                
             💬
 | [1]  ITGAL ITGAL 💬
 | [12]  Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [9]  11 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
 | 
| 145 | Raptiva 100 mg/ml powder and solvent for solution for injection | [1]  Efalizumab Efalizumab | [1]  Efalizumab 
                
                    Efalizumab
                
             💬
 | [1]  ITGAL ITGAL 💬
 | [12]  Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | [7]  11 11, 13, 46, 53, 61, 95, 96 💬
 | 
| 146 | RAS | - | - | - | - | [3]  6 6, 58, 66 💬
 | 
| 147 | RAS 2410 | - | - | - | - | [1]  66 66 💬
 | 
| 148 | Rasagilin | - | - | - | - | [2]  5 5, 6 💬
 | 
| 149 | Rasagilina | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2]  6 6, 17 💬
 | 
| 150 | RASAGILINA MESILATO | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2]  6 6, 17 💬
 | 
| 151 | Rasagilina mesilato (12 weeks) | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1]  6 6 💬
 | 
| 152 | Rasagiline | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [4]  2 2, 5, 6, 17 💬
 | 
| 153 | Rasagiline 1 mg capsule | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1]  6 6 💬
 | 
| 154 | Rasagiline 1mg tablet | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1]  6 6 💬
 | 
| 155 | Rasagiline 2 mg tablet | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1]  6 6 💬
 | 
| 156 | RASAGILINE MESILATE | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [3]  2 2, 5, 6 💬
 | 
| 157 | RASAGILINE MESYLATE | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2]  6 6, 17 💬
 | 
| 158 | Rasagiline mesylate 1.0 mg | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1]  6 6 💬
 | 
| 159 | Rasagiline mesylate plus Mirapex | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1]  6 6 💬
 | 
| 160 | Rasagiline mesylate with Levodopa | [2]  Levodopa Levodopa, Rasagiline | [3]  Levodopa 
                
                    Levodopa
                
            , 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [6]  DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, MAOB 💬
 | [20]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 161 | Rasagiline mesylate with Requip | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1]  6 6 💬
 | 
| 162 | Rasagiline tablets | [1]  Rasagiline Rasagiline | [2]  Rasagiline 
                
                    Rasagiline
                
            , 
                
                    Rasagiline tartrate
                
             💬
 | [1]  MAOB MAOB 💬
 | [14]  Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1]  6 6 💬
 | 
| 163 | Raspberry | [1]  Raspberry Raspberry | [1]  Raspberry 
                
                    Raspberry
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 164 | RATG | [1]  Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [4]  13 13, 51, 60, 285 💬
 | 
| 165 | Ravagalimab | [1]  Ravagalimab Ravagalimab | [1]  Ravagalimab 
                
                    Ravagalimab
                
             💬
 | [1]  CD40 CD40 💬
 | [17]  Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬 | [2]  53 53, 97 💬
 | 
| 166 | RAVICTI | [1]  Glycerol phenylbutyrate Glycerol phenylbutyrate | [1]  Glycerol phenylbutyrate 
                
                    Glycerol phenylbutyrate
                
             💬
 | - | - | [2]  251 251, 299 💬
 | 
| 167 | Ravicti high dose | [1]  Glycerol phenylbutyrate Glycerol phenylbutyrate | [1]  Glycerol phenylbutyrate 
                
                    Glycerol phenylbutyrate
                
             💬
 | - | - | [1]  299 299 💬
 | 
| 168 | Ravicti low dose | [1]  Glycerol phenylbutyrate Glycerol phenylbutyrate | [1]  Glycerol phenylbutyrate 
                
                    Glycerol phenylbutyrate
                
             💬
 | - | - | [1]  299 299 💬
 | 
| 169 | RAvPAL-PEG | [1]  Pegvaliase Pegvaliase | [1]  Pegvaliase 
                
                    Pegvaliase
                
             💬
 | [1]  PAH PAH 💬
 | [5]  Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1]  240 240 💬
 | 
| 170 | RAvPAL-PEG 0.001 mg/kg | [1]  Pegvaliase Pegvaliase | [1]  Pegvaliase 
                
                    Pegvaliase
                
             💬
 | [1]  PAH PAH 💬
 | [5]  Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1]  240 240 💬
 | 
| 171 | RAvPAL-PEG 0.003 mg/kg | [1]  Pegvaliase Pegvaliase | [1]  Pegvaliase 
                
                    Pegvaliase
                
             💬
 | [1]  PAH PAH 💬
 | [5]  Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1]  240 240 💬
 | 
| 172 | RAvPAL-PEG 0.01 mg/kg | [1]  Pegvaliase Pegvaliase | [1]  Pegvaliase 
                
                    Pegvaliase
                
             💬
 | [1]  PAH PAH 💬
 | [5]  Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1]  240 240 💬
 | 
| 173 | RAvPAL-PEG 0.03 mg/kg | [1]  Pegvaliase Pegvaliase | [1]  Pegvaliase 
                
                    Pegvaliase
                
             💬
 | [1]  PAH PAH 💬
 | [5]  Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1]  240 240 💬
 | 
| 174 | RAvPAL-PEG 0.1 mg/kg | [1]  Pegvaliase Pegvaliase | [1]  Pegvaliase 
                
                    Pegvaliase
                
             💬
 | [1]  PAH PAH 💬
 | [5]  Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | [1]  240 240 💬
 | 
| 175 | RAVULIZUMAB | [1]  Ravulizumab Ravulizumab | [1]  Ravulizumab 
                
                    Ravulizumab
                
             💬
 | [1]  C5 C5 💬
 | [11]  Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [7]  2 2, 11, 13, 50, 62, 66, 109 💬
 | 
| 176 | Raxone | [1]  Idebenone Idebenone | [1]  Idebenone 
                
                    Idebenone
                
             💬
 | - | - | [1]  113 113 💬
 | 
| 177 | RAXONE - 150 MG- COMPRESSE RIVESTITE CON FILM- USO ORALE- FLACONE (HDPE)- 180 COMPRESSE | [1]  Idebenone Idebenone | [1]  Idebenone 
                
                    Idebenone
                
             💬
 | - | - | [1]  113 113 💬
 | 
| 178 | RAYOS | [1]  Prednisone Prednisone | [1]  Prednisone 
                
                    Prednisone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  49 49 💬
 | 
| 179 | RAYOS (delayed-release prednisone) | [1]  Prednisone Prednisone | [1]  Prednisone 
                
                    Prednisone
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  46 46 💬
 | 
| 180 | RbATG | - | - | - | - | [2]  51 51, 96 💬
 | 
| 181 | RC18 160 mg | - | - | - | - | [2]  13 13, 53 💬
 | 
| 182 | RC18 160 mg plus MTX | - | - | - | - | [1]  46 46 💬
 | 
| 183 | RC18 160 mg plus standard therapy | - | - | - | - | [1]  49 49 💬
 | 
| 184 | RC18 160mg | - | - | - | - | [3]  11 11, 13, 66 💬
 | 
| 185 | RC18 240 mg | - | - | - | - | [2]  11 11, 53 💬
 | 
| 186 | RC18 240 mg plus standard therapy | - | - | - | - | [1]  49 49 💬
 | 
| 187 | RC18 240mg | - | - | - | - | [2]  13 13, 66 💬
 | 
| 188 | RC18 80 mg plus standard therapy | - | - | - | - | [1]  49 49 💬
 | 
| 189 | Rcombinant Human Parathyroid Hormone [rhPTH(1-84)] | [1]  Parathyroid hormone Parathyroid hormone | [1]  Parathyroid hormone 
                
                    Parathyroid hormone
                
             💬
 | [2]  PTH1R PTH1R, PTH2R 💬
 | [3]  Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1]  235 235 💬
 | 
| 190 | RCTB-401 | - | - | - | - | [1]  96 96 💬
 | 
| 191 | RDP58 | - | - | - | - | [1]  97 97 💬
 | 
| 192 | RE-021 | - | - | - | - | [3]  66 66, 218, 222 💬
 | 
| 193 | RE-021 (Sparsentan) | [1]  Sparsentan Sparsentan | [1]  Sparsentan 
                
                    Sparsentan
                
             💬
 | [2]  AGTR1 AGTR1, EDNRA 💬
 | [17]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1]  222 222 💬
 | 
| 194 | RE-024 | - | - | - | - | [1]  120 120 💬
 | 
| 195 | Reactive Corticosteroid Taper Regimen | - | - | - | - | [1]  251 251 💬
 | 
| 196 | Reagila | [1]  Cariprazine Cariprazine | [1]  Cariprazine 
                
                    Cariprazine
                
             💬
 | [3]  DRD2 DRD2, HTR1A, HTR2A 💬
 | [12]  Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [1]  21 21 💬
 | 
| 197 | Rebamipide | [1]  Rebamipide Rebamipide | [1]  Rebamipide 
                
                    Rebamipide
                
             💬
 | - | - | [4]  46 46, 53, 97, 271 💬
 | 
| 198 | REBIF | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 199 | Rebif (IFN beta-1a subcutaneous three times per week) | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 200 | Rebif (IFN ß-1a subcutaneous three times per week) | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 201 | Rebif (interferon beta 1a) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 202 | Rebif (Interferon beta-1a) | [2]  Human interferon beta Human interferon beta, Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 203 | Rebif (interferon beta-1a), Merck Serono Europe Ltd | [2]  Human interferon beta Human interferon beta, Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 204 | REBIF - 44 MCG(12 MILIONI UI) -SOLUZ INIETTABILE- USO SOTTOCUTANEO-PENNA PRERIEMPITA 0.5 ML (24 MILIONI UI/ML)12 PENNE PRERIEMPITE | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 205 | Rebif 22 | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 206 | Rebif 22 micrograms | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 207 | Rebif 22 y 44 mcg | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 208 | Rebif 22® | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 209 | Rebif 44 | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 210 | Rebif 44 microgrammi/0.5ml soluzione iniettabile in cartuccia | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 211 | REBIF 44 microgramos solución inyectable | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 212 | REBIF 44 microgramos solución inyectable en jeringa precargada | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 213 | Rebif 44 micrograms | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 214 | Rebif 44 micrograms solution for injection | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 215 | Rebif 44 micrograms solution for injection in pre-filled syringe | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 216 | Rebif 44 µg | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 217 | Rebif 44® | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 218 | Rebif 8,8 µg, Rebif 22µg | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 219 | Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 220 | Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack. | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 221 | Rebif New Formulation + ibuprofen PRN | [1]  Ibuprofen Ibuprofen | [1]  Ibuprofen 
                
                    Ibuprofen
                
             💬
 | [2]  PTGS1 PTGS1, PTGS2 💬
 | [23]  Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1]  13 13 💬
 | 
| 222 | Rebif New Formulation + prophylactic Ibuprofen | [1]  Ibuprofen Ibuprofen | [1]  Ibuprofen 
                
                    Ibuprofen
                
             💬
 | [2]  PTGS1 PTGS1, PTGS2 💬
 | [23]  Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1]  13 13 💬
 | 
| 223 | Rebif New Formulation 44mcg multidose cartridge | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 224 | Rebif New Formulation Non Titrated | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 225 | Rebif New Formulation Titrated | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 226 | REBIF SC 12SIR 12000000UI44MCG | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 227 | REBIF SC 12SIR 6000000UI 22MCG | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 228 | REBIF*SC 12SIR 12000000UI44MCG | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 229 | REBIF*SC 12SIR 6000000UI 22MCG | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 230 | Rebif® | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 231 | Rebif® (clone 484-39) | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 232 | Rebif® New Formulation | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 233 | Rebif® New Formulation (IFN-beta-1a, RNF) | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 234 | Rebif® new formulation (RNF) | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 235 | Rebif® New Formulation (RNF) using RebiSmartTM | [1]  Interferon beta-1a Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 236 | Rebisufligene etisparvovec | [1]  Rebisufligene etisparvovec Rebisufligene etisparvovec | - | - | - | [1]  19 19 💬
 | 
| 237 | REC-2282 | - | - | - | - | [1]  34 34 💬
 | 
| 238 | Rec-h-FGF19 | - | - | - | - | [1]  94 94 💬
 | 
| 239 | Received hormone maintenance therapy | - | - | - | - | [1]  96 96 💬
 | 
| 240 | Recifercept | - | - | - | - | [1]  276 276 💬
 | 
| 241 | Recifercept (proposed INN) | - | - | - | - | [1]  276 276 💬
 | 
| 242 | Recombiant human Desoxyribonuclease ( rhDNase) | [1]  Desoxyribonuclease Desoxyribonuclease | - | - | - | [1]  299 299 💬
 | 
| 243 | Recombinanat DNA-derived human growth | - | - | - | - | [1]  78 78 💬
 | 
| 244 | Recombinanat DNA-derived human growth hormone produced in E.coli | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 245 | Recombinant A Disintegrin and Metalloproteinase Thrombospondin Type-1 Motifs 13 | - | - | - | - | [1]  64 64 💬
 | 
| 246 | Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1 | - | - | - | - | [1]  64 64 💬
 | 
| 247 | Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1 Motifs | - | - | - | - | [1]  64 64 💬
 | 
| 248 | Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1 Motifs 13 | - | - | - | - | [1]  64 64 💬
 | 
| 249 | Recombinant A Disintegrin And Metalloproteinase with Thrombospondin Type-1 Motifs 13 (rADAMTS13) | - | - | - | - | [1]  64 64 💬
 | 
| 250 | Recombinant AAV vector serotype 2 containing the human wild type mitochondrial ND4 gene | - | - | - | - | [1]  302 302 💬
 | 
| 251 | Recombinant AAV vector serotype 2 containing the human wild typemitochondrial ND4 gene | - | - | - | - | [1]  302 302 💬
 | 
| 252 | Recombinant ADAMTS13 | - | - | - | - | [1]  64 64 💬
 | 
| 253 | RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR EXPRESSING THE HUMAN ALPHA-1-ANTITRYPSIN GENE | [1]  Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | [1]  231 231 💬
 | 
| 254 | Recombinant adeno-associated viral vector serotype 2.7m8 containing the ChrimsonR-tdTomato gene | - | - | - | - | [1]  90 90 💬
 | 
| 255 | Recombinant Adeno-Associated Viral vector, serotype 2 (rAAV2/2) containing the human wild-type mitochondrial NADH Dehydrogenase 4 gene (ND4) | [1]  NADH NADH | - | - | - | [1]  302 302 💬
 | 
| 256 | Recombinant Adeno-associated virus 2/6 vector encoding the cDNA for human alpha galactosidase A | - | - | - | - | [1]  19 19 💬
 | 
| 257 | Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase | [1]  Alglucosidase alfa Alglucosidase alfa | [1]  Alglucosidase alfa 
                
                    Alglucosidase alfa
                
             💬
 | [1]  GAA GAA 💬
 | [4]  Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | [1]  256 256 💬
 | 
| 258 | Recombinant adenovirus containing the ornithine transcarbamylase gene | [1]  Ornithine Ornithine | [1]  Ornithine 
                
                    Ornithine
                
             💬
 | - | - | [1]  251 251 💬
 | 
| 259 | Recombinant alpha-galactosidase A | [1]  Agalsidase alfa Agalsidase alfa | [1]  Agalsidase alfa 
                
                    Agalsidase alfa
                
             💬
 | [1]  GLA GLA 💬
 | [6]  Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1]  19 19 💬
 | 
| 260 | Recombinant antihumanized anti-human monoclonal antibody directed against the IL-6R | - | - | - | - | [1]  107 107 💬
 | 
| 261 | Recombinant coagulation FVIII Fc – von Willebrand factor – XTEN fusion protein | [1]  Von Willebrand factor human Von Willebrand factor human | - | - | - | [1]  288 288 💬
 | 
| 262 | Recombinant coagulation FVIII Fc –von Willebrand factor – XTEN fusion protein | [1]  Von Willebrand factor human Von Willebrand factor human | - | - | - | [1]  288 288 💬
 | 
| 263 | Recombinant DNA-derived human growth hormone | [1]  Somatotropin Somatotropin | - | - | - | [2]  78 78, 187 💬
 | 
| 264 | Recombinant DNA-derived human growth hormone produced in E.coli | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 265 | RECOMBINANT FACTOR FC FUSION PROTEIN | [2]  Iron polymaltose Iron polymaltose, Lactobacillus casei | [1]  Lactobacillus casei 
                
                    Lactobacillus casei
                
             💬
 | - | - | [2]  46 46, 49 💬
 | 
| 266 | Recombinant factor VIIII (rFVIII) | - | - | - | - | [1]  288 288 💬
 | 
| 267 | Recombinant Factor XIII | [1]  Factor XIII (human) Factor XIII (human) | - | - | - | [1]  288 288 💬
 | 
| 268 | Recombinant Factor XIII (rFXIII) | [1]  Factor XIII (human) Factor XIII (human) | - | - | - | [2]  97 97, 288 💬
 | 
| 269 | Recombinant form of human nerve growth factor produced in Escherichia Coli. | [2]  Escherichia coli Escherichia coli, Nerve Growth Factor | - | - | - | [1]  53 53 💬
 | 
| 270 | Recombinant granulocyte - colony stimulating factor | - | - | - | - | [1]  39 39 💬
 | 
| 271 | Recombinant growth hormone | [1]  Somatotropin Somatotropin | - | - | - | [2]  78 78, 96 💬
 | 
| 272 | Recombinant Growth Hormone, Genotropin (Pfizer) | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 273 | RECOMBINANT HUMAN ?-GLUCOSIDASE CONJUGATED WITH SYNTHETIC BISMANNOSE-6-PHOSPHATE-MAN6 GLYCAN | [1]  Phosphate ion Phosphate ion | - | - | - | [1]  256 256 💬
 | 
| 274 | Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan (NEOGAA) | [3]  Avalglucosidase alfa Avalglucosidase alfa, Mannose, Phosphate ion | [1]  Avalglucosidase alfa 
                
                    Avalglucosidase alfa
                
             💬
 | [1]  GAA GAA 💬
 | [4]  Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | [1]  256 256 💬
 | 
| 275 | Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan Avalglucosidase Alfa (NeoGAA) | [3]  Avalglucosidase alfa Avalglucosidase alfa, Mannose, Phosphate ion | [1]  Avalglucosidase alfa 
                
                    Avalglucosidase alfa
                
             💬
 | [1]  GAA GAA 💬
 | [4]  Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | [1]  256 256 💬
 | 
| 276 | Recombinant human acid alfa-glucosidase | - | - | - | - | [1]  256 256 💬
 | 
| 277 | Recombinant human acid alfa-glucosidase (ATB200) | - | - | - | - | [1]  256 256 💬
 | 
| 278 | Recombinant human acid alfa-glucosidase (rhGAA) | - | - | - | - | [1]  256 256 💬
 | 
| 279 | Recombinant human acid alpha-glucosidase (rhGAA) | [1]  Alglucosidase alfa Alglucosidase alfa | [1]  Alglucosidase alfa 
                
                    Alglucosidase alfa
                
             💬
 | [1]  GAA GAA 💬
 | [4]  Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | [1]  256 256 💬
 | 
| 280 | Recombinant human acid sphingomyelinase | - | - | - | - | [1]  19 19 💬
 | 
| 281 | RECOMBINANT HUMAN ACID SPHINGOMYELINASE (rhASM) | - | - | - | - | [1]  19 19 💬
 | 
| 282 | RECOMBINANT HUMAN ALFA-GLUCOSIDASE CONJUGATED WITH SYNTHETIC BISMANNOSE-6-PHOSPHATE-MAN6 GLYCAN | [1]  Phosphate ion Phosphate ion | - | - | - | [1]  256 256 💬
 | 
| 283 | Recombinant human alpha B-crystallin | - | - | - | - | [1]  13 13 💬
 | 
| 284 | Recombinant human alpha-galactosidase | - | - | - | - | [1]  19 19 💬
 | 
| 285 | Recombinant human alpha-galactosidase abbreviated as r-h-alpha-GAL | - | - | - | - | [1]  19 19 💬
 | 
| 286 | Recombinant human alpha-mannosidase | - | - | - | - | [1]  19 19 💬
 | 
| 287 | Recombinant Human Alpha-N-Acetylglucosaminidase (rhNAGLU) | - | - | - | - | [1]  19 19 💬
 | 
| 288 | Recombinant Human Angiotensin-Converting Enzyme 2 | [2]  Alunacedase alfa Alunacedase alfa, Angiotensin II | [2]  Angiotensin II 
                
                    Angiotensin II
                
            , 
                
                    Angiotensin II
                
             💬
 | [2]  AGTR1 AGTR1, AGTR2 💬
 | [16]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 289 | Recombinant Human Angiotensin-converting enzyme 2 (ACE2), APN01 | [2]  Alunacedase alfa Alunacedase alfa, Angiotensin II | [2]  Angiotensin II 
                
                    Angiotensin II
                
            , 
                
                    Angiotensin II
                
             💬
 | [2]  AGTR1 AGTR1, AGTR2 💬
 | [16]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 290 | Recombinant human anti IL-22 monoclonal antibody IgG1 | - | - | - | - | [1]  46 46 💬
 | 
| 291 | Recombinant human anti-GDF-8 antibody | - | - | - | - | [1]  113 113 💬
 | 
| 292 | Recombinant Human Apolipoprotein | - | - | - | - | [1]  79 79 💬
 | 
| 293 | Recombinant Human Apolipoprotein A-I | - | - | - | - | [1]  79 79 💬
 | 
| 294 | Recombinant Human Apolipoprotein A-I/Phospholipids Complex | [1]  Omega-3 fatty acids Omega-3 fatty acids | - | - | - | [1]  79 79 💬
 | 
| 295 | Recombinant human apolipoprotein a1 | - | - | - | - | [1]  79 79 💬
 | 
| 296 | RECOMBINANT HUMAN ARYLSULFATASE A | - | - | - | - | [1]  19 19 💬
 | 
| 297 | Recombinant Human Arylsulfatase A (rhASA) | - | - | - | - | [1]  19 19 💬
 | 
| 298 | Recombinant Human Arylsulfatase A (rhASA, | - | - | - | - | [1]  19 19 💬
 | 
| 299 | Recombinant human Arysulfatase B, recombinant human N-acetylgalactosamine 4-sulfatase | - | - | - | - | [1]  19 19 💬
 | 
| 300 | RECOMBINANT HUMAN BETA GLUCURONIDASE | - | - | - | - | [1]  19 19 💬
 | 
| 301 | Recombinant human beta-glucuronidase | [1]  Vestronidase alfa Vestronidase alfa | [1]  Vestronidase alfa 
                
                    Vestronidase alfa
                
             💬
 | [1]  GUSB GUSB 💬
 | [8]  Ascorbate and aldarate metabolism Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬 | [1]  19 19 💬
 | 
| 302 | Recombinant human beta-glucuronidase (rhGUS) | [1]  Vestronidase alfa Vestronidase alfa | [1]  Vestronidase alfa 
                
                    Vestronidase alfa
                
             💬
 | [1]  GUSB GUSB 💬
 | [8]  Ascorbate and aldarate metabolism Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬 | [1]  19 19 💬
 | 
| 303 | Recombinant human betaglucuronidase | - | - | - | - | [1]  19 19 💬
 | 
| 304 | Recombinant human brain natriuretic peptide (rhBNP) | - | - | - | - | [1]  215 215 💬
 | 
| 305 | Recombinant human Cerebral Dopamine Neurotrophic Factor | [1]  Dopamine Dopamine | [1]  Dopamine 
                
                    Dopamine
                
             💬
 | [5]  DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
 | [11]  Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 306 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTO | [2]  Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | [1]  288 288 💬
 | 
| 307 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - | [3]  Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1]  288 288 💬
 | 
| 308 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - XTEN FUSION PROTEIN | [3]  Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1]  288 288 💬
 | 
| 309 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR -XTEN FUSION PROTEIN | [3]  Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1]  288 288 💬
 | 
| 310 | Recombinant human derived macrophage-targeted beta-Glucocerebrosidase | - | - | - | - | [1]  19 19 💬
 | 
| 311 | Recombinant human derived macrophage-targeted ß-Glucocerebrosidase | - | - | - | - | [1]  19 19 💬
 | 
| 312 | Recombinant Human DNase (Pulmozyme) | [1]  Dornase alfa Dornase alfa | [1]  Dornase alfa 
                
                    Dornase alfa
                
             💬
 | - | - | [1]  299 299 💬
 | 
| 313 | RECOMBINANT HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 FUSED TO THE FC FRAGMENT OF IGG1 | - | - | - | - | [1]  166 166 💬
 | 
| 314 | Recombinant Human Erythropoietin | [1]  Erythropoietin Erythropoietin | - | - | - | [1]  13 13 💬
 | 
| 315 | Recombinant human erythropoietin(rhEPO) | [1]  Erythropoietin Erythropoietin | - | - | - | [1]  2 2 💬
 | 
| 316 | Recombinant human glucerebrosidase | - | - | - | - | [1]  19 19 💬
 | 
| 317 | Recombinant human glucocerebrosidase | - | - | - | - | [1]  19 19 💬
 | 
| 318 | Recombinant Human Glucocerebrosidase (prGCD) | [1]  Taliglucerase alfa Taliglucerase alfa | [1]  Taliglucerase alfa 
                
                    Taliglucerase alfa
                
             💬
 | [1]  GBA1 GBA1 💬
 | [4]  Lysosome Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬 | [1]  19 19 💬
 | 
| 319 | Recombinant Human Gowth Hormone | - | - | - | - | [1]  78 78 💬
 | 
| 320 | RECOMBINANT HUMAN GROWTH HORMON | - | - | - | - | [1]  193 193 💬
 | 
| 321 | RECOMBINANT HUMAN GROWTH HORMONE | [1]  Somatotropin Somatotropin | - | - | - | [4]  78 78, 193, 265, 276 💬
 | 
| 322 | Recombinant human Growth Hormone (Genotropin® ) | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 323 | Recombinant human growth hormone (r-hGH) | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 324 | Recombinant human Growth Hormone (rhGH) | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 325 | Recombinant Human Growth Hormone (rhGH) Injection | [1]  Somatotropin Somatotropin | - | - | - | [1]  193 193 💬
 | 
| 326 | Recombinant human growth hormone + rosiglitazone | [2]  Rosiglitazone Rosiglitazone, Somatotropin | [1]  Rosiglitazone 
                
                    Rosiglitazone
                
             💬
 | [1]  PPARG PPARG 💬
 | [11]  AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1]  265 265 💬
 | 
| 327 | Recombinant human Growth Hormone(rhGH) | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 328 | Recombinant human heparan N-sulfatase | - | - | - | - | [1]  19 19 💬
 | 
| 329 | Recombinant human heparan N-sulfatase (rhHNS) | - | - | - | - | [1]  19 19 💬
 | 
| 330 | Recombinant human heparan N-sulfatase [rhHNS] | - | - | - | - | [1]  19 19 💬
 | 
| 331 | Recombinant human heparan Nsulfatase (rhHNS) | - | - | - | - | [1]  19 19 💬
 | 
| 332 | Recombinant human hyaluronidase | [2]  Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) | [3]  Hyaluronidase 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
             💬
 | - | - | [3]  14 14, 28, 65 💬
 | 
| 333 | Recombinant Human Hyaluronidase (rHuPH20) | [2]  Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) | [3]  Hyaluronidase 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
             💬
 | - | - | [1]  65 65 💬
 | 
| 334 | Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV) | [2]  Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) | [3]  Hyaluronidase 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
             💬
 | - | - | [1]  65 65 💬
 | 
| 335 | Recombinant human hyaluronidase + immune globulin intravenous | [2]  Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) | [3]  Hyaluronidase 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
             💬
 | - | - | [1]  65 65 💬
 | 
| 336 | Recombinant human hyaluronidase PH20 | [2]  Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) | [3]  Hyaluronidase 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
             💬
 | - | - | [1]  28 28 💬
 | 
| 337 | Recombinant human IFN beta | - | - | - | - | [1]  13 13 💬
 | 
| 338 | Recombinant human IGF-1 | - | - | - | - | [2]  78 78, 299 💬
 | 
| 339 | Recombinant Human Insulin Growth Factor 1 (rhIGF-1) | [1]  Insulin human Insulin human | [1]  Insulin human 
                
                    Insulin human
                
             💬
 | [1]  INSR INSR 💬
 | [22]  AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1]  156 156 💬
 | 
| 340 | Recombinant human Insulin-like Growth Factor | [1]  Insulin human Insulin human | [1]  Insulin human 
                
                    Insulin human
                
             💬
 | [1]  INSR INSR 💬
 | [22]  AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1]  96 96 💬
 | 
| 341 | Recombinant human interferon beta | [1]  Human interferon beta Human interferon beta | - | - | - | [1]  13 13 💬
 | 
| 342 | Recombinant human interferon beta-1a | [2]  Human interferon beta Human interferon beta, Interferon beta-1a | [1]  Interferon beta-1a 
                
                    Interferon beta-1a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  26 26 💬
 | 
| 343 | Recombinant Human Interleukin-11 (rhIL-11) | [1]  Oprelvekin Oprelvekin | [1]  Oprelvekin 
                
                    Oprelvekin
                
             💬
 | [1]  IL11RA IL11RA 💬
 | [3]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1]  96 96 💬
 | 
| 344 | Recombinant human interleukin-2 | [2]  Aldesleukin Aldesleukin, Human interleukin-2 | [1]  Aldesleukin 
                
                    Aldesleukin
                
             💬
 | [3]  IL2RA IL2RA, IL2RB, IL2RG 💬
 | [14]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  35 35 💬
 | 
| 345 | Recombinant human interleukin-2 (rhIL-2) | [2]  Aldesleukin Aldesleukin, Human interleukin-2 | [1]  Aldesleukin 
                
                    Aldesleukin
                
             💬
 | [3]  IL2RA IL2RA, IL2RB, IL2RG 💬
 | [14]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  35 35 💬
 | 
| 346 | Recombinant human interleukin-7 | [1]  Interleukin-7 Interleukin-7 | - | - | - | [1]  25 25 💬
 | 
| 347 | Recombinant human lysosomal acid lipase | - | - | - | - | [1]  19 19 💬
 | 
| 348 | Recombinant human lysosomal acid lipase (rhLAL) | - | - | - | - | [1]  19 19 💬
 | 
| 349 | Recombinant human lysosomal acid lipase (rhLAL), esterase, cholesterol (human gene LIPA) | [1]  Cholesterol Cholesterol | [1]  Cholesterol 
                
                    Cholesterol
                
             💬
 | - | - | [1]  19 19 💬
 | 
| 350 | Recombinant human lysosomal acid lipase (rhLAL), esterase, cholesterol (human gene LIPA), lysosomal acid lipase (human gene LIPA) | [1]  Cholesterol Cholesterol | [1]  Cholesterol 
                
                    Cholesterol
                
             💬
 | - | - | [1]  19 19 💬
 | 
| 351 | Recombinant human lysosomal alpha-mannosidase | - | - | - | - | [1]  19 19 💬
 | 
| 352 | Recombinant human Mab of IgG4 subtype | - | - | - | - | [1]  46 46 💬
 | 
| 353 | Recombinant human monoclonal antibody | - | - | - | - | [1]  46 46 💬
 | 
| 354 | Recombinant human monoclonal antibody to human IL-1Beta of the IgG1/K class | - | - | - | - | [3]  106 106, 107, 108 💬
 | 
| 355 | Recombinant human monoclonal antibody to Il-17 of the IgG1-k-class | - | - | - | - | [1]  271 271 💬
 | 
| 356 | Recombinant human monoclonal antibody to inerleukin-1beta of the IgG1-K-class | - | - | - | - | [1]  46 46 💬
 | 
| 357 | Recombinant human monoclonal antibody to interleukin-1beta of the IgG1-Kappa-class | - | - | - | - | [1]  46 46 💬
 | 
| 358 | Recombinant human N-acetylgalactosamine 4-sulfatase | - | - | - | - | [1]  19 19 💬
 | 
| 359 | Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110 | - | - | - | - | [1]  19 19 💬
 | 
| 360 | Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110 drug substance | - | - | - | - | [1]  19 19 💬
 | 
| 361 | Recombinant human N-acetylgalactosamine-6-sulfatase | [1]  Elosulfase alfa Elosulfase alfa | [1]  Elosulfase alfa 
                
                    Elosulfase alfa
                
             💬
 | [1]  GALNS GALNS 💬
 | [3]  Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1]  19 19 💬
 | 
| 362 | Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) | [1]  Elosulfase alfa Elosulfase alfa | [1]  Elosulfase alfa 
                
                    Elosulfase alfa
                
             💬
 | [1]  GALNS GALNS 💬
 | [3]  Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1]  19 19 💬
 | 
| 363 | Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 | [1]  Elosulfase alfa Elosulfase alfa | [1]  Elosulfase alfa 
                
                    Elosulfase alfa
                
             💬
 | [1]  GALNS GALNS 💬
 | [3]  Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1]  19 19 💬
 | 
| 364 | Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 drug substance | [1]  Elosulfase alfa Elosulfase alfa | [1]  Elosulfase alfa 
                
                    Elosulfase alfa
                
             💬
 | [1]  GALNS GALNS 💬
 | [3]  Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1]  19 19 💬
 | 
| 365 | Recombinant human Nacetylgalactosamine- | - | - | - | - | [1]  19 19 💬
 | 
| 366 | Recombinant Human Nerve Growth Factor (rhNGF) | [2]  Cenegermin Cenegermin, Nerve Growth Factor | [1]  Cenegermin 
                
                    Cenegermin
                
             💬
 | [1]  NGFR NGFR 💬
 | [9]  Apoptosis - multiple species Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Lyssavirus 💬 | [2]  53 53, 90 💬
 | 
| 367 | RECOMBINANT HUMAN PARATHYROID HORMONE (1-84) | [1]  Parathyroid hormone Parathyroid hormone | [1]  Parathyroid hormone 
                
                    Parathyroid hormone
                
             💬
 | [2]  PTH1R PTH1R, PTH2R 💬
 | [3]  Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1]  235 235 💬
 | 
| 368 | Recombinant Human Parathyroid Hormone [rhPTH(1-84)] | [1]  Parathyroid hormone Parathyroid hormone | [1]  Parathyroid hormone 
                
                    Parathyroid hormone
                
             💬
 | [2]  PTH1R PTH1R, PTH2R 💬
 | [3]  Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1]  235 235 💬
 | 
| 369 | Recombinant human Pentraxin-2 | - | - | - | - | [1]  85 85 💬
 | 
| 370 | Recombinant human Pentraxin-2 (PRM-151) | [1]  PRM-151 PRM-151 | - | - | - | [1]  85 85 💬
 | 
| 371 | Recombinant human porphobilinogen deaminase (Porphozym) | [1]  Porphobilinogen Porphobilinogen | - | - | - | [1]  254 254 💬
 | 
| 372 | RECOMBINANT HUMAN SERUM ALBUMIN (HSA) FUSED TO HUMAN GROWTH HORMONE (HGH) | [2]  Albumin human Albumin human, Somatotropin | [1]  Albumin human 
                
                    Albumin human
                
             💬
 | - | - | [1]  78 78 💬
 | 
| 373 | Recombinant human somatotropin | [1]  Somatotropin Somatotropin | - | - | - | [2]  78 78, 236 💬
 | 
| 374 | Recombinant Human Thrombopoietin | [2]  Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Thrombopoietin | - | - | - | [1]  63 63 💬
 | 
| 375 | Recombinant human thrombopoietin (rh-TPO) | [2]  Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Thrombopoietin | - | - | - | [1]  63 63 💬
 | 
| 376 | Recombinant Human Thrombopoietin (rhTPO) | [2]  Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Thrombopoietin | - | - | - | [1]  63 63 💬
 | 
| 377 | Recombinant human tripeptidyl peptidase-1 | - | - | - | - | [1]  19 19 💬
 | 
| 378 | RECOMBINANT HUMAN TRIPEPTIDYL PEPTIDASE-1 (RHTPP1) | - | - | - | - | [1]  19 19 💬
 | 
| 379 | Recombinant human von Willebrand Factor | [1]  Von Willebrand factor human Von Willebrand factor human | - | - | - | [1]  288 288 💬
 | 
| 380 | Recombinant humanised anti-human monoclonal antibody directed against the IL-6R | - | - | - | - | [1]  46 46 💬
 | 
| 381 | Recombinant humanized anti-alpha 4 integrin antibody | - | - | - | - | [1]  13 13 💬
 | 
| 382 | Recombinant humanized anti-CD20 monoclonal antibody | - | - | - | - | [1]  13 13 💬
 | 
| 383 | Recombinant humanized anti-human Interleukin 6-Receptor (IL-6R) monoclonal | - | - | - | - | [1]  46 46 💬
 | 
| 384 | Recombinant humanized anti-human Interleukin 6-Receptor (IL-6R) monoclonal antibody | - | - | - | - | [1]  46 46 💬
 | 
| 385 | Recombinant humanized anti-human Interleukin-6 | - | - | - | - | [1]  46 46 💬
 | 
| 386 | Recombinant humanized anti-human Interleukin-6 Receptor (IL-6R) monoclonal antibody | - | - | - | - | [1]  46 46 💬
 | 
| 387 | Recombinant humanized anti-human monoclonal antibody directed against the IL-6R | - | - | - | - | [3]  46 46, 51, 107 💬
 | 
| 388 | Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg | - | - | - | - | [1]  331 331 💬
 | 
| 389 | Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 6mg/kg | - | - | - | - | [1]  331 331 💬
 | 
| 390 | Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 8mg/kg | - | - | - | - | [1]  331 331 💬
 | 
| 391 | Recombinant humanized IgG4 monoclonal antibody | - | - | - | - | [1]  61 61 💬
 | 
| 392 | Recombinant humanized monoclonal antibody omalizumab to IgE | [1]  Omalizumab Omalizumab | [1]  Omalizumab 
                
                    Omalizumab
                
             💬
 | [1]  FCER1A FCER1A 💬
 | [4]  Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | [1]  299 299 💬
 | 
| 393 | Recombinant humanized monoclonal antibody specific for human IL-5 | - | - | - | - | [1]  44 44 💬
 | 
| 394 | Recombinant humanized monoclonal antibody: IgG4 (heavy chain) | - | - | - | - | [1]  61 61 💬
 | 
| 395 | Recombinant interferon alfa | [1]  Interferon alfa Interferon alfa | [1]  Interferon alfa 
                
                    Interferon alfa
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2]  26 26, 28 💬
 | 
| 396 | RECOMBINANT INTERFERON BE | - | - | - | - | [1]  13 13 💬
 | 
| 397 | RECOMBINANT INTERFERON BETA-1B | [2]  Human interferon beta Human interferon beta, Interferon beta-1b | [1]  Interferon beta-1b 
                
                    Interferon beta-1b
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  13 13 💬
 | 
| 398 | Recombinant interleukin-11 | [1]  Oprelvekin Oprelvekin | [1]  Oprelvekin 
                
                    Oprelvekin
                
             💬
 | [1]  IL11RA IL11RA 💬
 | [3]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1]  288 288 💬
 | 
| 399 | Recombinant LCAT | - | - | - | - | [1]  259 259 💬
 | 
| 400 | Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) | - | - | - | - | [1]  60 60 💬
 | 
| 401 | Recombinant microbial lipase | - | - | - | - | [1]  298 298 💬
 | 
| 402 | Recombinant Microbial Lipase SLV339 | - | - | - | - | [1]  298 298 💬
 | 
| 403 | RECOMBINANT NEISSERIA | - | - | - | - | [1]  11 11 💬
 | 
| 404 | RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E.COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE | [5]  Aluminium Aluminium, Aluminum hydroxide, Hydroxide ion, Iron polymaltose, Lactobacillus casei | [2]  Aluminum hydroxide 
                
                    Aluminum hydroxide
                
            , 
                
                    Lactobacillus casei
                
             💬
 | - | - | [1]  11 11 💬
 | 
| 405 | RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN | - | - | - | - | [1]  11 11 💬
 | 
| 406 | RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN | [2]  Iron polymaltose Iron polymaltose, Lactobacillus casei | [1]  Lactobacillus casei 
                
                    Lactobacillus casei
                
             💬
 | - | - | [2]  11 11, 13 💬
 | 
| 407 | Recombinant porcine coagulation factor VIII (B domain deleted) | [1]  Beroctocog alfa Beroctocog alfa | - | - | - | [1]  288 288 💬
 | 
| 408 | Recombinant porcine coagulation factor VIII (B-domain deleted) | [1]  Beroctocog alfa Beroctocog alfa | - | - | - | [1]  288 288 💬
 | 
| 409 | Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN6 gene | - | - | - | - | [1]  19 19 💬
 | 
| 410 | Recombinant Somatropin | [1]  Somatotropin Somatotropin | - | - | - | [1]  193 193 💬
 | 
| 411 | Recombinant TNF-a receptor: IgG Fc fusion protein | [2]  Iron polymaltose Iron polymaltose, Lactobacillus casei | [1]  Lactobacillus casei 
                
                    Lactobacillus casei
                
             💬
 | - | - | [2]  46 46, 271 💬
 | 
| 412 | Recombinant truncated SPINT2 protease inhibitor | - | - | - | - | [1]  299 299 💬
 | 
| 413 | Recombinant von Willebrand Factor | [1]  Von Willebrand factor human Von Willebrand factor human | - | - | - | [1]  288 288 💬
 | 
| 414 | Recombinant von Willebrand Factor (rVWF) | [1]  Von Willebrand factor human Von Willebrand factor human | - | - | - | [1]  288 288 💬
 | 
| 415 | Recombinant von Willebrand Factor 1300IU | [1]  Von Willebrand factor human Von Willebrand factor human | - | - | - | [1]  288 288 💬
 | 
| 416 | Recombinant von Willebrand Factor 650IU | [1]  Von Willebrand factor human Von Willebrand factor human | - | - | - | [1]  288 288 💬
 | 
| 417 | Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII) | [1]  Von Willebrand factor human Von Willebrand factor human | - | - | - | [1]  288 288 💬
 | 
| 418 | Recombinant zoster vaccine | - | - | - | - | [2]  13 13, 49 💬
 | 
| 419 | Recombinant-methionyl human glial cell line-derived neurotrophic factor | - | - | - | - | [1]  6 6 💬
 | 
| 420 | Recombinat human growth hormone | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 421 | Recomibnant human Von Willebrand Factor | [1]  Von Willebrand factor human Von Willebrand factor human | - | - | - | [1]  288 288 💬
 | 
| 422 | RECTABUL2mg rectal form | - | - | - | - | [1]  97 97 💬
 | 
| 423 | Rectal dialysis | - | - | - | - | [1]  97 97 💬
 | 
| 424 | Rectal tacrolimus | [1]  Tacrolimus Tacrolimus | [2]  Tacrolimus 
                
                    Tacrolimus
                
            , 
                
                    Tacrolimus
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1]  97 97 💬
 | 
| 425 | Red Blood Cell Zn | - | - | - | - | [1]  299 299 💬
 | 
| 426 | Reditux | - | - | - | - | [1]  46 46 💬
 | 
| 427 | Reduced Glutathione | [1]  Glutathione Glutathione | [2]  Glutathione 
                
                    Glutathione
                
            , 
                
                    Oxiglutatione
                
             💬
 | - | - | [2]  6 6, 299 💬
 | 
| 428 | Reduced Glutathione 100mg | [1]  Glutathione Glutathione | [2]  Glutathione 
                
                    Glutathione
                
            , 
                
                    Oxiglutatione
                
             💬
 | - | - | [1]  6 6 💬
 | 
| 429 | Reduced Glutathione 200mg | [1]  Glutathione Glutathione | [2]  Glutathione 
                
                    Glutathione
                
            , 
                
                    Oxiglutatione
                
             💬
 | - | - | [1]  6 6 💬
 | 
| 430 | Reduced glutathione sodium salt | [1]  Glutathione Glutathione | [2]  Glutathione 
                
                    Glutathione
                
            , 
                
                    Oxiglutatione
                
             💬
 | - | - | [1]  299 299 💬
 | 
| 431 | Reduced Intensity Conditioning | - | - | - | - | [2]  19 19, 65 💬
 | 
| 432 | Reduced Intensity Preparative Regimen | - | - | - | - | [3]  62 62, 65, 284 💬
 | 
| 433 | Reduced Toxicity Ablative Regimen | - | - | - | - | [3]  62 62, 65, 284 💬
 | 
| 434 | REF CRUZADA PEI Nº 12-088 | - | - | - | - | [1]  274 274 💬
 | 
| 435 | Reference capsule GDC-0134 | [1]  GDC-0134 GDC-0134 | - | - | - | [1]  2 2 💬
 | 
| 436 | Refresh Endura | [1]  Boscalid Boscalid | - | - | - | [1]  53 53 💬
 | 
| 437 | Regadenoson | [1]  Regadenoson Regadenoson | [2]  Regadenoson 
                
                    Regadenoson
                
            , 
                
                    Regadenoson
                
             💬
 | [1]  ADORA2A ADORA2A 💬
 | [7]  Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1]  58 58 💬
 | 
| 438 | REGE pro dressing | - | - | - | - | [1]  36 36 💬
 | 
| 439 | REGEND001 Autologous Therapy Product | - | - | - | - | [1]  85 85 💬
 | 
| 440 | Regimen Selection Phase Group 1 (COMPLETED) | - | - | - | - | [1]  113 113 💬
 | 
| 441 | Regimen Selection Phase Group 2 | - | - | - | - | [1]  113 113 💬
 | 
| 442 | Regimen Selection Phase Group 3 | - | - | - | - | [1]  113 113 💬
 | 
| 443 | REGN1500 | - | - | - | - | [1]  79 79 💬
 | 
| 444 | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | - | - | - | - | [1]  79 79 💬
 | 
| 445 | REGN2477 | - | - | - | - | [1]  272 272 💬
 | 
| 446 | REGN2477+REGN1033 | - | - | - | - | [1]  15 15 💬
 | 
| 447 | REGN3918 | - | - | - | - | [2]  11 11, 62 💬
 | 
| 448 | REGN4461 | - | - | - | - | [1]  265 265 💬
 | 
| 449 | REGN475/SAR164877 | - | - | - | - | [1]  298 298 💬
 | 
| 450 | REGN7257 | - | - | - | - | [1]  60 60 💬
 | 
| 451 | REGN7272 | - | - | - | - | [1]  79 79 💬
 | 
| 452 | REGN88 | [1]  Sarilumab Sarilumab | [1]  Sarilumab 
                
                    Sarilumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2]  46 46, 107 💬
 | 
| 453 | Regular insulin | - | - | - | - | [1]  78 78 💬
 | 
| 454 | Regular Novolin R | - | - | - | - | [1]  6 6 💬
 | 
| 455 | Regular treatment | - | - | - | - | [1]  97 97 💬
 | 
| 456 | Regulatory T cells | - | - | - | - | [2]  95 95, 97 💬
 | 
| 457 | Reh-acteoside | [1]  Acteoside Acteoside | - | - | - | [1]  66 66 💬
 | 
| 458 | Relacorilant | [1]  Relacorilant Relacorilant | [1]  Relacorilant 
                
                    Relacorilant
                
             💬
 | [1]  NR3C1 NR3C1 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1]  75 75 💬
 | 
| 459 | Relaxin | - | - | - | - | [1]  51 51 💬
 | 
| 460 | RELDESEMTIV | [1]  Reldesemtiv Reldesemtiv | [1]  Reldesemtiv 
                
                    Reldesemtiv
                
             💬
 | [1]  TNNC2 TNNC2 💬
 | [1]  Calcium signaling pathway Calcium signaling pathway 💬 | [2]  2 2, 3 💬
 | 
| 461 | Reldesemtiv 150 mg | [1]  Reldesemtiv Reldesemtiv | [1]  Reldesemtiv 
                
                    Reldesemtiv
                
             💬
 | [1]  TNNC2 TNNC2 💬
 | [1]  Calcium signaling pathway Calcium signaling pathway 💬 | [1]  3 3 💬
 | 
| 462 | Reldesemtiv 450 mg | [1]  Reldesemtiv Reldesemtiv | [1]  Reldesemtiv 
                
                    Reldesemtiv
                
             💬
 | [1]  TNNC2 TNNC2 💬
 | [1]  Calcium signaling pathway Calcium signaling pathway 💬 | [1]  3 3 💬
 | 
| 463 | Release | [1]  Manganese citrate Manganese citrate | - | - | - | [12]  6 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299 💬
 | 
| 464 | Relebactam | [1]  Relebactam Relebactam | [1]  Relebactam 
                
                    Relebactam
                
             💬
 | - | - | [1]  299 299 💬
 | 
| 465 | Relma-cel | - | - | - | - | [1]  49 49 💬
 | 
| 466 | Relovade | - | - | - | - | [1]  63 63 💬
 | 
| 467 | Remestemcel-L | [1]  Remestemcel-L Remestemcel-L | [1]  Remestemcel-L 
                
                    Remestemcel-L
                
             💬
 | - | - | [2]  96 96, 97 💬
 | 
| 468 | Remibrutinib | [1]  Remibrutinib Remibrutinib | [1]  Remibrutinib 
                
                    Remibrutinib
                
             💬
 | [1]  BTK BTK 💬
 | [7]  B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | [2]  13 13, 53 💬
 | 
| 469 | Remicade | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [9]  40 40, 46, 49, 56, 84, 85, 96, 97, 271 💬
 | 
| 470 | Remicade (anti tumor necrosis factor inhibitor) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  40 40 💬
 | 
| 471 | REMICADE (INFLIXIMAB) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 96, 97 💬
 | 
| 472 | REMICADE - 100 MG POLVERE PER CONCENTRATO PER INFUSIONE ENDOVENOSA 1 FLACONE VETRO 20 ML USO EV | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 473 | Remicade 100 mg | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  56 56, 96 💬
 | 
| 474 | Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 475 | REMICADE 100 mg polvo para concentrado para solución para perfusión | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  46 46, 271 💬
 | 
| 476 | Remicade 100 mg powder for concentrate for solution for infusion. | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 477 | Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  46 46, 96, 97, 271 💬
 | 
| 478 | Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning. | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 479 | REMICADE*EV F 100MG+F 2ML | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 480 | Remicade® | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  46 46, 271 💬
 | 
| 481 | REMICADE® (Infliximab) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 482 | Remicaide (infliximab) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  39 39 💬
 | 
| 483 | Remifentanil | [1]  Remifentanil Remifentanil | [1]  Remifentanil 
                
                    Remifentanil
                
             💬
 | [1]  OPRM1 OPRM1 💬
 | [3]  Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [2]  6 6, 70 💬
 | 
| 484 | Remifentanyl | [1]  Remifentanil Remifentanil | [1]  Remifentanil 
                
                    Remifentanil
                
             💬
 | [1]  OPRM1 OPRM1 💬
 | [3]  Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1]  6 6 💬
 | 
| 485 | Reminder capsules | - | - | - | - | [1]  19 19 💬
 | 
| 486 | Reminder Product | - | - | - | - | [1]  19 19 💬
 | 
| 487 | Reminyl | - | - | - | - | [1]  6 6 💬
 | 
| 488 | Reminyl Retard | - | - | - | - | [1]  6 6 💬
 | 
| 489 | Remisma | - | - | - | - | [1]  96 96 💬
 | 
| 490 | Remission induction therapy | - | - | - | - | [2]  43 43, 44 💬
 | 
| 491 | Remodulin | [1]  Treprostinil Treprostinil | [1]  Treprostinil 
                
                    Treprostinil
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [2]  86 86, 88 💬
 | 
| 492 | Remodulin (R) | [1]  Treprostinil Treprostinil | [1]  Treprostinil 
                
                    Treprostinil
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1]  88 88 💬
 | 
| 493 | Remodulin (treprostinil sodium) | [1]  Treprostinil Treprostinil | [1]  Treprostinil 
                
                    Treprostinil
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1]  86 86 💬
 | 
| 494 | Remodulin 10mg/ml 20ml | [1]  Treprostinil Treprostinil | [1]  Treprostinil 
                
                    Treprostinil
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1]  88 88 💬
 | 
| 495 | Remodulin 1mg/ml 20ml | [1]  Treprostinil Treprostinil | [1]  Treprostinil 
                
                    Treprostinil
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1]  88 88 💬
 | 
| 496 | Remodulin 2.5mg/ml 20ml | [1]  Treprostinil Treprostinil | [1]  Treprostinil 
                
                    Treprostinil
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1]  88 88 💬
 | 
| 497 | Remodulin 5mg/ml 20ml | [1]  Treprostinil Treprostinil | [1]  Treprostinil 
                
                    Treprostinil
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1]  88 88 💬
 | 
| 498 | Remodulin® (treprostinil) 1 mg/ml solution for infusion | [1]  Treprostinil Treprostinil | [1]  Treprostinil 
                
                    Treprostinil
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1]  86 86 💬
 | 
| 499 | Remodulin® (treprostinil) 10 mg/ml solution for infusion | [1]  Treprostinil Treprostinil | [1]  Treprostinil 
                
                    Treprostinil
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1]  86 86 💬
 | 
| 500 | Remodulin® (treprostinil) 2.5 mg/ml solution for infusion | [1]  Treprostinil Treprostinil | [1]  Treprostinil 
                
                    Treprostinil
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1]  86 86 💬
 | 
| 501 | Remodulin® (treprostinil) 5 mg/ml solution for infusion | [1]  Treprostinil Treprostinil | [1]  Treprostinil 
                
                    Treprostinil
                
             💬
 | [1]  PTGIR PTGIR 💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1]  86 86 💬
 | 
| 502 | REMSIMA | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  46 46, 96, 97, 271 💬
 | 
| 503 | Remsima (CT-P13) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  97 97 💬
 | 
| 504 | Remsima (infliximab) | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3]  46 46, 96, 97 💬
 | 
| 505 | REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  46 46, 96, 97, 271 💬
 | 
| 506 | Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4]  46 46, 96, 97, 271 💬
 | 
| 507 | Remsima and Inflectra | [1]  Infliximab Infliximab | [1]  Infliximab 
                
                    Infliximab
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2]  96 96, 97 💬
 | 
| 508 | REMSINA | - | - | - | - | [1]  96 96 💬
 | 
| 509 | REN001 | [1]  ReN001 ReN001 | - | - | - | [1]  256 256 💬
 | 
| 510 | Renin Angiotensin system (RAS) blockade or Inhibitors of sodium glucose transporter 2 (SGLT2i) | [2]  Angiotensin II Angiotensin II, Dextrose, unspecified form | [2]  Angiotensin II 
                
                    Angiotensin II
                
            , 
                
                    Angiotensin II
                
             💬
 | [2]  AGTR1 AGTR1, AGTR2 💬
 | [16]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  66 66 💬
 | 
| 511 | Repagermanium | - | - | - | - | [1]  222 222 💬
 | 
| 512 | Repaglinide | [1]  Repaglinide Repaglinide | [1]  Repaglinide 
                
                    Repaglinide
                
             💬
 | [2]  ABCC8 ABCC8, KCNJ11 💬
 | [4]  ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [4]  6 6, 21, 46, 299 💬
 | 
| 513 | Repaglinide and Insulin | [1]  Repaglinide Repaglinide | [1]  Repaglinide 
                
                    Repaglinide
                
             💬
 | [2]  ABCC8 ABCC8, KCNJ11 💬
 | [4]  ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [1]  299 299 💬
 | 
| 514 | Repaglinide Tablets | [1]  Repaglinide Repaglinide | [1]  Repaglinide 
                
                    Repaglinide
                
             💬
 | [2]  ABCC8 ABCC8, KCNJ11 💬
 | [4]  ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [1]  46 46 💬
 | 
| 515 | Reparixin | [1]  Reparixin Reparixin | [1]  Reparixin 
                
                    Reparixin
                
             💬
 | [2]  CXCR1 CXCR1, CXCR2 💬
 | [7]  Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [2]  298 298, 299 💬
 | 
| 516 | Repatha | [1]  Evolocumab Evolocumab | [1]  Evolocumab 
                
                    Evolocumab
                
             💬
 | [1]  PCSK9 PCSK9 💬
 | [1]  Cholesterol metabolism Cholesterol metabolism 💬 | [1]  79 79 💬
 | 
| 517 | Repatha (evolocumab) | [1]  Evolocumab Evolocumab | [1]  Evolocumab 
                
                    Evolocumab
                
             💬
 | [1]  PCSK9 PCSK9 💬
 | [1]  Cholesterol metabolism Cholesterol metabolism 💬 | [1]  79 79 💬
 | 
| 518 | Repatha 140 mg Solution for Injection in Pre-filled Pen | [1]  Evolocumab Evolocumab | [1]  Evolocumab 
                
                    Evolocumab
                
             💬
 | [1]  PCSK9 PCSK9 💬
 | [1]  Cholesterol metabolism Cholesterol metabolism 💬 | [1]  79 79 💬
 | 
| 519 | Repatha 140 mg soluzione per iniezione in penna preriempita. | [1]  Evolocumab Evolocumab | [1]  Evolocumab 
                
                    Evolocumab
                
             💬
 | [1]  PCSK9 PCSK9 💬
 | [1]  Cholesterol metabolism Cholesterol metabolism 💬 | [1]  79 79 💬
 | 
| 520 | Repatha 420 mg solution for injection in cartridge | [1]  Evolocumab Evolocumab | [1]  Evolocumab 
                
                    Evolocumab
                
             💬
 | [1]  PCSK9 PCSK9 💬
 | [1]  Cholesterol metabolism Cholesterol metabolism 💬 | [1]  79 79 💬
 | 
| 521 | Repatha 420 mg soluzione per iniezione in cartuccia | [1]  Evolocumab Evolocumab | [1]  Evolocumab 
                
                    Evolocumab
                
             💬
 | [1]  PCSK9 PCSK9 💬
 | [1]  Cholesterol metabolism Cholesterol metabolism 💬 | [1]  79 79 💬
 | 
| 522 | REPLAGAL | [1]  Agalsidase alfa Agalsidase alfa | [1]  Agalsidase alfa 
                
                    Agalsidase alfa
                
             💬
 | [1]  GLA GLA 💬
 | [6]  Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1]  19 19 💬
 | 
| 523 | Replagal (Agalsidase Alfa) | [1]  Agalsidase alfa Agalsidase alfa | [1]  Agalsidase alfa 
                
                    Agalsidase alfa
                
             💬
 | [1]  GLA GLA 💬
 | [6]  Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1]  19 19 💬
 | 
| 524 | Replagal agalsidase alfa | [1]  Agalsidase alfa Agalsidase alfa | [1]  Agalsidase alfa 
                
                    Agalsidase alfa
                
             💬
 | [1]  GLA GLA 💬
 | [6]  Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1]  19 19 💬
 | 
| 525 | REPLAGAL ® | [1]  Agalsidase alfa Agalsidase alfa | [1]  Agalsidase alfa 
                
                    Agalsidase alfa
                
             💬
 | [1]  GLA GLA 💬
 | [6]  Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | [1]  19 19 💬
 | 
| 526 | Repomol | - | - | - | - | [1]  97 97 💬
 | 
| 527 | Repository corticotropin injection | [1]  Corticotropin Corticotropin | [1]  Corticotropin 
                
                    Corticotropin
                
             💬
 | [1]  MC2R MC2R 💬
 | [5]  Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [5]  2 2, 13, 46, 84, 222 💬
 | 
| 528 | Reproxalap | [1]  Reproxalap Reproxalap | [1]  Reproxalap 
                
                    Reproxalap
                
             💬
 | - | - | [1]  160 160 💬
 | 
| 529 | REQUIP | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [2]  6 6, 309 💬
 | 
| 530 | REQUIP 21 CPR 0,25 MG | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 531 | REQUIP 21 CPR 0,5 MG | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 532 | REQUIP 21 CPR 1 MG | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 533 | REQUIP 21 CPR 2 MG | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 534 | ReQuip CR | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [2]  2 2, 6 💬
 | 
| 535 | Requip CR tablets | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  2 2 💬
 | 
| 536 | Requip Modutab, 2mg | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 537 | Requip Modutab, 4mg | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 538 | Requip Modutab, 8mg | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 539 | ReQuip PR | - | - | - | - | [1]  6 6 💬
 | 
| 540 | Requip prolonged release | [2]  Manganese citrate Manganese citrate, Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 541 | Requip XL prolonged-release | [2]  Manganese citrate Manganese citrate, Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 542 | REQUIP*21CPR 0,25MG | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 543 | REQUIP*21CPR 0,5MG | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 544 | REQUIP*21CPR 1MG | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 545 | REQUIP*21CPR 5MG | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 546 | REQUIP*28CPR 8MG R.P. | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 547 | REQUIP-LP | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 548 | Requip-Modutab | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 549 | REQUIP-MODUTAB , 2mg | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 550 | REQUIP-MODUTAB , 4mg | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 551 | REQUIP-MODUTAB , 8mg | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 552 | REQUIP-MODUTAB, 2mg | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 553 | REQUIP-MODUTAB, 4mg | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 554 | REQUIP-MODUTAB, 8mg | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 555 | Rescue Medication CDCA 250 mg TID | [1]  Chenodeoxycholic acid Chenodeoxycholic acid | [1]  Chenodiol 
                
                    Chenodiol
                
             💬
 | [1]  NR1H4 NR1H4 💬
 | [1]  Bile secretion Bile secretion 💬 | [1]  263 263 💬
 | 
| 556 | Resistant maltodextrin | [1]  Maltodextrin Maltodextrin | [1]  Maltodextrin 
                
                    Maltodextrin
                
             💬
 | - | - | [1]  6 6 💬
 | 
| 557 | Resistant starch | - | - | - | - | [1]  6 6 💬
 | 
| 558 | Reslizumab | [1]  Reslizumab Reslizumab | [1]  Reslizumab 
                
                    Reslizumab
                
             💬
 | [1]  IL5 IL5 💬
 | [13]  Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [2]  44 44, 98 💬
 | 
| 559 | Resolor | [1]  Prucalopride Prucalopride | [1]  Prucalopride 
                
                    Prucalopride
                
             💬
 | [1]  HTR4 HTR4 💬
 | [4]  Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [1]  51 51 💬
 | 
| 560 | RESOLOR*28CPR RIV 2MG | [1]  Prucalopride Prucalopride | [1]  Prucalopride 
                
                    Prucalopride
                
             💬
 | [1]  HTR4 HTR4 💬
 | [4]  Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [1]  51 51 💬
 | 
| 561 | Response to anakinra associated with methotrexate | [2]  Anakinra Anakinra, Methotrexate | [2]  Methotrexate 
                
                    Methotrexate
                
            , 
                
                    Anakinra
                
             💬
 | [4]  DHFR DHFR, DHFR2, IL1R1, IL1R2 💬
 | [20]  Amoebiasis Amoebiasis, Antifolate resistance, Biosynthesis of cofactors, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Folate biosynthesis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Metabolic pathways, NF-kappa B signaling pathway, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [1]  46 46 💬
 | 
| 562 | Response to infliximab associated with methotrexate | [2]  Infliximab Infliximab, Methotrexate | [2]  Methotrexate 
                
                    Methotrexate
                
            , 
                
                    Infliximab
                
             💬
 | [3]  DHFR DHFR, DHFR2, TNF 💬
 | [71]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 563 | Restasis | [1]  Cyclosporine Cyclosporine | [1]  Cyclosporine 
                
                    Cyclosporine
                
             💬
 | [5]  PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [33]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2]  53 53, 162 💬
 | 
| 564 | Restex Tabletten | - | - | - | - | [1]  6 6 💬
 | 
| 565 | Resunab, ajulemic acid, anabasum | [1]  Ajulemic acid Ajulemic acid | [1]  Lenabasum 
                
                    Lenabasum
                
             💬
 | [1]  CNR2 CNR2 💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3]  50 50, 51, 299 💬
 | 
| 566 | Resveratrol | [1]  Resveratrol Resveratrol | - | - | - | [6]  2 2, 8, 18, 89, 97, 113 💬
 | 
| 567 | Resveratrol Supplementation | [1]  Resveratrol Resveratrol | - | - | - | [1]  97 97 💬
 | 
| 568 | Retarded release phosphatidylcholine | [1]  Lecithin Lecithin | [1]  Lecithin 
                
                    Lecithin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 569 | Retarded Release Phosphatidylcholine (rPC) | [1]  Lecithin Lecithin | [1]  Lecithin 
                
                    Lecithin
                
             💬
 | - | - | [1]  97 97 💬
 | 
| 570 | RETIGABINE | [1]  Ezogabine Ezogabine | [1]  Ezogabine 
                
                    Ezogabine
                
             💬
 | [5]  KCNQ1 KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬
 | [6]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬 | [2]  2 2, 144 💬
 | 
| 571 | RETIGABINE/EZOGABINE | [1]  Ezogabine Ezogabine | [1]  Ezogabine 
                
                    Ezogabine
                
             💬
 | [5]  KCNQ1 KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬
 | [6]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬 | [1]  144 144 💬
 | 
| 572 | Retinal pigment epitheliums transplantation | - | - | - | - | [1]  90 90 💬
 | 
| 573 | Retinoic acid | [1]  Tretinoin Tretinoin | [1]  Tretinoin 
                
                    Tretinoin
                
             💬
 | [3]  PML PML, RARA, RARB 💬
 | [12]  Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | [2]  94 94, 231 💬
 | 
| 574 | Retinoic Acid Receptor gamma Agonist | [1]  Tretinoin Tretinoin | [1]  Tretinoin 
                
                    Tretinoin
                
             💬
 | [3]  PML PML, RARA, RARB 💬
 | [12]  Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | [1]  231 231 💬
 | 
| 575 | Retrospective Case Only | - | - | - | - | [1]  172 172 💬
 | 
| 576 | Retrovir | [1]  Zidovudine Zidovudine | [1]  Zidovudine 
                
                    Zidovudine
                
             💬
 | - | - | [1]  135 135 💬
 | 
| 577 | Retroviral SF71-gp91phox transduced CD34+ cells | - | - | - | - | [1]  65 65 💬
 | 
| 578 | Retrovirus Construct | - | - | - | - | [1]  285 285 💬
 | 
| 579 | Rett-T | - | - | - | - | [1]  156 156 💬
 | 
| 580 | Reumaflex | - | - | - | - | [1]  107 107 💬
 | 
| 581 | Reumatocept (etanercept) | [1]  Etanercept Etanercept | [1]  Etanercept 
                
                    Etanercept
                
             💬
 | [2]  LTA LTA, TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  46 46 💬
 | 
| 582 | Revamilast | [1]  Revamilast Revamilast | - | - | - | [1]  46 46 💬
 | 
| 583 | Revatio | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [3]  85 85, 86, 113 💬
 | 
| 584 | REVATIO - 0.8 MG/ML - SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO DA 20 ML | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  294 294 💬
 | 
| 585 | Revatio 0.8mg/ml solution for injection | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  294 294 💬
 | 
| 586 | Revatio 10 mg/ml powder for oral suspension | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 587 | Revatio 20 mg | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  85 85 💬
 | 
| 588 | Revatio 20 mg film coated tablets | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 589 | Revatio 20 mg film-coated tablets | - | - | - | - | [1]  86 86 💬
 | 
| 590 | Revatio 20 mg Filmtabletten | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 591 | REVATIO 20 mg, comprimidos recubiertos con película | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 592 | Revatio inyectable | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 593 | Revatio oral | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 594 | Revatio POS | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 595 | Revatio Tablets | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 596 | Revatio ® 20 mg film-coated tablets | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 597 | Revatio® | [1]  Sildenafil Sildenafil | [1]  Sildenafil 
                
                    Sildenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 598 | REVAXIS | - | - | - | - | [1]  13 13 💬
 | 
| 599 | Reveglucosidase alfa | - | - | - | - | [1]  256 256 💬
 | 
| 600 | Reveglucosidase alpha | - | - | - | - | [1]  256 256 💬
 | 
| 601 | Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir | [3]  Abacavir Abacavir, Lamivudine, Zidovudine | [3]  Lamivudine 
                
                    Lamivudine
                
            , 
                
                    Zidovudine
                
            , 
                
                    Abacavir
                
             💬
 | - | - | [1]  325 325 💬
 | 
| 602 | REVLIMID | [1]  Lenalidomide Lenalidomide | [1]  Lenalidomide 
                
                    Lenalidomide
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  28 28 💬
 | 
| 603 | REVLIMID*21CPS 25MG | [1]  Lenalidomide Lenalidomide | [1]  Lenalidomide 
                
                    Lenalidomide
                
             💬
 | [1]  TNF TNF 💬
 | [67]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1]  16 16 💬
 | 
| 604 | REVOLADE | [1]  Eltrombopag Eltrombopag | - | - | - | [2]  60 60, 63 💬
 | 
| 605 | REVOLADE - 25 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU) 28 COMPRESSE | [1]  Eltrombopag Eltrombopag | - | - | - | [1]  60 60 💬
 | 
| 606 | REVOLADE - 50 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU | [1]  Eltrombopag Eltrombopag | - | - | - | [1]  60 60 💬
 | 
| 607 | Revolade 25 mg film-coated tablets | [1]  Eltrombopag Eltrombopag | - | - | - | [1]  63 63 💬
 | 
| 608 | Revolade 50 mg film-coated tablets | [1]  Eltrombopag Eltrombopag | - | - | - | [1]  63 63 💬
 | 
| 609 | Revolade 75 mg | [1]  Eltrombopag Eltrombopag | - | - | - | [1]  60 60 💬
 | 
| 610 | REVOLADE, PROMACTA | [1]  Eltrombopag Eltrombopag | - | - | - | [1]  63 63 💬
 | 
| 611 | Revusiran | [1]  Revusiran Revusiran | - | - | - | [1]  28 28 💬
 | 
| 612 | Rexlemestrocel-L | - | - | - | - | [2]  210 210, 211 💬
 | 
| 613 | Reyataz | [1]  Atazanavir Atazanavir | [1]  Atazanavir 
                
                    Atazanavir
                
             💬
 | - | - | [1]  265 265 💬
 | 
| 614 | REYATAZ 150MG 60 CPS BL | [1]  Atazanavir Atazanavir | [1]  Atazanavir 
                
                    Atazanavir
                
             💬
 | - | - | [1]  265 265 💬
 | 
| 615 | RFB002 | - | - | - | - | [1]  166 166 💬
 | 
| 616 | RFB002, rhuFab V2 | [1]  Ranibizumab Ranibizumab | [1]  Ranibizumab 
                
                    Ranibizumab
                
             💬
 | [1]  VEGFA VEGFA 💬
 | [24]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [1]  166 166 💬
 | 
| 617 | RFB002A | - | - | - | - | [1]  166 166 💬
 | 
| 618 | RFP | - | - | - | - | [1]  338 338 💬
 | 
| 619 | RFVIIa | [1]  Coagulation factor VIIa Recombinant Human Coagulation factor VIIa Recombinant Human | - | - | - | [1]  288 288 💬
 | 
| 620 | RFVIIa, rFVIIa + TXA | [1]  Coagulation factor VIIa Recombinant Human Coagulation factor VIIa Recombinant Human | - | - | - | [1]  288 288 💬
 | 
| 621 | RFVIII | - | - | - | - | [1]  288 288 💬
 | 
| 622 | RG-012 | - | - | - | - | [1]  218 218 💬
 | 
| 623 | RG012 | - | - | - | - | [1]  218 218 💬
 | 
| 624 | RG1068 (Synthetic Human Secretin) | [1]  Secretin human Secretin human | - | - | - | [1]  298 298 💬
 | 
| 625 | RG2077 (CTLA4-IgG4m) | - | - | - | - | [1]  13 13 💬
 | 
| 626 | RG2133 (2',3',5'-tri-O-acetyluridine) | [1]  Uridine triacetate Uridine triacetate | [1]  Uridine triacetate 
                
                    Uridine triacetate
                
             💬
 | - | - | [1]  21 21 💬
 | 
| 627 | RG6042, formerly ISIS 443139, IONIS-HTTRx | - | - | - | - | [1]  8 8 💬
 | 
| 628 | RGB-03 | - | - | - | - | [1]  46 46 💬
 | 
| 629 | RGH-706 | - | - | - | - | [1]  193 193 💬
 | 
| 630 | RGLS4326 | - | - | - | - | [1]  67 67 💬
 | 
| 631 | RGLS8429 | - | - | - | - | [1]  67 67 💬
 | 
| 632 | RGX-111 | - | - | - | - | [1]  19 19 💬
 | 
| 633 | RGX-121 | - | - | - | - | [1]  19 19 💬
 | 
| 634 | RGX-202 | - | - | - | - | [1]  113 113 💬
 | 
| 635 | Rh Growth Hormone | [1]  Somatotropin Somatotropin | - | - | - | [1]  19 19 💬
 | 
| 636 | Rhamnose | [1]  Rhamnose Rhamnose | - | - | - | [1]  96 96 💬
 | 
| 637 | RhARSA | - | - | - | - | [1]  19 19 💬
 | 
| 638 | RhASA | - | - | - | - | [1]  19 19 💬
 | 
| 639 | RhASA - Dose Level 1 | - | - | - | - | [1]  19 19 💬
 | 
| 640 | RhASA - Dose Level 2 | - | - | - | - | [1]  19 19 💬
 | 
| 641 | RhASA - Dose Level 3 | - | - | - | - | [1]  19 19 💬
 | 
| 642 | RhASM | - | - | - | - | [1]  19 19 💬
 | 
| 643 | RHB-104 | - | - | - | - | [2]  13 13, 96 💬
 | 
| 644 | RhBSSL | [1]  Bucelipase alfa Bucelipase alfa | - | - | - | [1]  299 299 💬
 | 
| 645 | RhDNAse | - | - | - | - | [1]  299 299 💬
 | 
| 646 | RhEPO | - | - | - | - | [1]  13 13 💬
 | 
| 647 | Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs) | - | - | - | - | [1]  46 46 💬
 | 
| 648 | RhGAA | - | - | - | - | [1]  256 256 💬
 | 
| 649 | RhGAA, acid alpha glucosidase | - | - | - | - | [1]  256 256 💬
 | 
| 650 | RhGALNS | [1]  Elosulfase alfa Elosulfase alfa | [1]  Elosulfase alfa 
                
                    Elosulfase alfa
                
             💬
 | [1]  GALNS GALNS 💬
 | [3]  Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | [1]  19 19 💬
 | 
| 651 | RhGH | [1]  Somatotropin Somatotropin | - | - | - | [6]  76 76, 78, 96, 193, 246, 337 💬
 | 
| 652 | RhGH Norditropin® pen (34 µg/kg) | [1]  Somatotropin Somatotropin | - | - | - | [1]  78 78 💬
 | 
| 653 | RhGM-CSF | [1]  Regramostim Regramostim | [1]  Regramostim 
                
                    Regramostim
                
             💬
 | [1]  CSF2RA CSF2RA 💬
 | [4]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1]  229 229 💬
 | 
| 654 | RHGUS | - | - | - | - | [1]  19 19 💬
 | 
| 655 | RhHNS-10 mg | - | - | - | - | [1]  19 19 💬
 | 
| 656 | RhHNS-45 mg | - | - | - | - | [1]  19 19 💬
 | 
| 657 | RhHNS-90 mg | - | - | - | - | [1]  19 19 💬
 | 
| 658 | RhIDU (recombinant human-Alpha-L-Iduronidase) | - | - | - | - | [1]  19 19 💬
 | 
| 659 | RhIFN beta-1b | - | - | - | - | [1]  13 13 💬
 | 
| 660 | RhIGF (Increlex) | [1]  Mecasermin Mecasermin | [1]  Mecasermin 
                
                    Mecasermin
                
             💬
 | [2]  GHR GHR, IGF1R 💬
 | [33]  AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1]  96 96 💬
 | 
| 661 | RhIGF-1 | - | - | - | - | [1]  156 156 💬
 | 
| 662 | RhIGF-1 (CEP-151) | - | - | - | - | [1]  13 13 💬
 | 
| 663 | RhIGF-1/rhIGFBP-3 | [1]  rhIGFBP-3 rhIGFBP-3 | - | - | - | [1]  195 195 💬
 | 
| 664 | RhIGF-I/rhIGFBP-3 | [1]  rhIGFBP-3 rhIGFBP-3 | - | - | - | [1]  113 113 💬
 | 
| 665 | RhIGFBP-3 | [1]  rhIGFBP-3 rhIGFBP-3 | - | - | - | [2]  113 113, 195 💬
 | 
| 666 | RHIgM22 | - | - | - | - | [1]  13 13 💬
 | 
| 667 | RhIL-11 | - | - | - | - | [1]  97 97 💬
 | 
| 668 | RhLAMAN | [1]  Velmanase alfa Velmanase alfa | [1]  Velmanase alfa 
                
                    Velmanase alfa
                
             💬
 | [1]  MAN2B1 MAN2B1 💬
 | [2]  Lysosome Lysosome, Other glycan degradation 💬 | [1]  19 19 💬
 | 
| 669 | RhNAGLU | - | - | - | - | [1]  19 19 💬
 | 
| 670 | RhNAGLU radiolabelled | - | - | - | - | [1]  19 19 💬
 | 
| 671 | RHNAGLU-IGF2 | - | - | - | - | [1]  19 19 💬
 | 
| 672 | RhNGF | [1]  Cenegermin Cenegermin | [1]  Cenegermin 
                
                    Cenegermin
                
             💬
 | [1]  NGFR NGFR 💬
 | [9]  Apoptosis - multiple species Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Lyssavirus 💬 | [2]  53 53, 90 💬
 | 
| 673 | RhNGF 180 µg/ml eye drops solution | [1]  Cenegermin Cenegermin | [1]  Cenegermin 
                
                    Cenegermin
                
             💬
 | [1]  NGFR NGFR 💬
 | [9]  Apoptosis - multiple species Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Lyssavirus 💬 | [1]  90 90 💬
 | 
| 674 | RhNGF 60 µg/ml eye drops solution | [1]  Cenegermin Cenegermin | [1]  Cenegermin 
                
                    Cenegermin
                
             💬
 | [1]  NGFR NGFR 💬
 | [9]  Apoptosis - multiple species Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Lyssavirus 💬 | [1]  90 90 💬
 | 
| 675 | RhPTH | [1]  Parathyroid hormone Parathyroid hormone | [1]  Parathyroid hormone 
                
                    Parathyroid hormone
                
             💬
 | [2]  PTH1R PTH1R, PTH2R 💬
 | [3]  Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [3]  70 70, 235, 326 💬
 | 
| 676 | RhPTH (1-34) | [1]  Parathyroid hormone Parathyroid hormone | [1]  Parathyroid hormone 
                
                    Parathyroid hormone
                
             💬
 | [2]  PTH1R PTH1R, PTH2R 💬
 | [3]  Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1]  70 70 💬
 | 
| 677 | RhPTH (1-84) | [1]  Parathyroid hormone Parathyroid hormone | [1]  Parathyroid hormone 
                
                    Parathyroid hormone
                
             💬
 | [2]  PTH1R PTH1R, PTH2R 💬
 | [3]  Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1]  235 235 💬
 | 
| 678 | RhPTH(1-84) | [1]  Parathyroid hormone Parathyroid hormone | [1]  Parathyroid hormone 
                
                    Parathyroid hormone
                
             💬
 | [2]  PTH1R PTH1R, PTH2R 💬
 | [3]  Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1]  235 235 💬
 | 
| 679 | RhTPO | [1]  Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin | - | - | - | [2]  60 60, 63 💬
 | 
| 680 | RhTPO in combination with Rituximab | [2]  Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  63 63 💬
 | 
| 681 | RhuCD40L | - | - | - | - | [1]  65 65 💬
 | 
| 682 | RhuDex 100 mg (127 mg RhuDex choline salt) granules | [1]  Choline Choline | [1]  Choline 
                
                    Choline
                
             💬
 | - | - | [1]  93 93 💬
 | 
| 683 | RhuDex 25 mg (31.75 mg RhuDex choline salt) granules | [1]  Choline Choline | [1]  Choline 
                
                    Choline
                
             💬
 | - | - | [1]  93 93 💬
 | 
| 684 | RhuDex 50 mg (63.5 mg RhuDex choline salt) granules | [1]  Choline Choline | [1]  Choline 
                
                    Choline
                
             💬
 | - | - | [1]  93 93 💬
 | 
| 685 | RhuDex choline salt | [1]  Choline Choline | [1]  Choline 
                
                    Choline
                
             💬
 | - | - | [1]  93 93 💬
 | 
| 686 | RhuFab V2 | [1]  Ranibizumab Ranibizumab | [1]  Ranibizumab 
                
                    Ranibizumab
                
             💬
 | [1]  VEGFA VEGFA 💬
 | [24]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [1]  166 166 💬
 | 
| 687 | RHuG-CSF | - | - | - | - | [1]  18 18 💬
 | 
| 688 | RhuMAb 2H7 | [1]  Ocrelizumab Ocrelizumab | [1]  Ocrelizumab 
                
                    Ocrelizumab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3]  13 13, 46, 49 💬
 | 
| 689 | RhuMAb Beta7 | - | - | - | - | [1]  97 97 💬
 | 
| 690 | RhuMAb Beta7, Anti Beta 7, PRO145223 | - | - | - | - | [1]  97 97 💬
 | 
| 691 | RhuMAb Beta7, Anti Beta7, PRO145223 | - | - | - | - | [1]  97 97 💬
 | 
| 692 | RhuMAb IFNalpha | - | - | - | - | [1]  49 49 💬
 | 
| 693 | RhumAb to Il-17A (IgG1-k-class) | - | - | - | - | [4]  13 13, 46, 56, 96 💬
 | 
| 694 | RhumAb to Il-17A (IgG1-k-class) rhumAb to Il-17A (IgG1-k-class) | - | - | - | - | [1]  96 96 💬
 | 
| 695 | RhumAb to IL-17A igG1-k-class | - | - | - | - | [1]  13 13 💬
 | 
| 696 | RHuPH20 | - | - | - | - | [2]  13 13, 14 💬
 | 
| 697 | Rhustoxicodendron 30 | - | - | - | - | [1]  46 46 💬
 | 
| 698 | RhuTNFR:Fc | - | - | - | - | [2]  46 46, 271 💬
 | 
| 699 | RI-002 | - | - | - | - | [1]  65 65 💬
 | 
| 700 | RIBAVIRIN | [1]  Ribavirin Ribavirin | [1]  Ribavirin 
                
                    Ribavirin
                
             💬
 | - | - | [2]  2 2, 96 💬
 | 
| 701 | Ribazen | - | - | - | - | [1]  46 46 💬
 | 
| 702 | Riboflavin | [1]  Riboflavin Riboflavin | [1]  Riboflavin 
                
                    Riboflavin
                
             💬
 | - | - | [7]  38 38, 46, 96, 97, 162, 168, 265 💬
 | 
| 703 | Riboflavin Sodium Phosphate Injection | [2]  Phosphate ion Phosphate ion, Riboflavin | [1]  Riboflavin 
                
                    Riboflavin
                
             💬
 | - | - | [1]  96 96 💬
 | 
| 704 | Riboflavin supplementation | [1]  Riboflavin Riboflavin | [1]  Riboflavin 
                
                    Riboflavin
                
             💬
 | - | - | [1]  96 96 💬
 | 
| 705 | Ribose | [1]  Ribose Ribose | - | - | - | [1]  131 131 💬
 | 
| 706 | RIC alloBMT w PTCy in refractory SSc | - | - | - | - | [1]  51 51 💬
 | 
| 707 | Rice | [1]  Rice Rice | - | - | - | [1]  53 53 💬
 | 
| 708 | Rice/turkey free diet (R/TFD) group | [2]  Rice Rice, Turkey | - | - | - | [1]  53 53 💬
 | 
| 709 | Riciguat Group | - | - | - | - | [1]  86 86 💬
 | 
| 710 | RIFABUTIN | [1]  Rifabutin Rifabutin | [1]  Rifabutin 
                
                    Rifabutin
                
             💬
 | - | - | [1]  96 96 💬
 | 
| 711 | Rifabutin, Clarithromycin, and Clofazimine | [3]  Clarithromycin Clarithromycin, Clofazimine, Rifabutin | [3]  Clarithromycin 
                
                    Clarithromycin
                
            , 
                
                    Clofazimine
                
            , 
                
                    Rifabutin
                
             💬
 | - | - | [1]  96 96 💬
 | 
| 712 | Rifampicin | [1]  Rifampicin Rifampicin | [1]  Rifampin 
                
                    Rifampin
                
             💬
 | - | - | [6]  6 6, 17, 46, 93, 299, 338 💬
 | 
| 713 | Rifampin | [1]  Rifampicin Rifampicin | [1]  Rifampin 
                
                    Rifampin
                
             💬
 | - | - | [5]  6 6, 13, 84, 86, 299 💬
 | 
| 714 | Rifampin 300mg BID + istradefylline 40mg Day 8 only | [2]  Istradefylline Istradefylline, Rifampicin | [2]  Rifampin 
                
                    Rifampin
                
            , 
                
                    Istradefylline
                
             💬
 | [1]  ADORA2A ADORA2A 💬
 | [7]  Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 715 | Rifampin and azithromycin. | [2]  Azithromycin Azithromycin, Rifampicin | [3]  Rifampin 
                
                    Rifampin
                
            , 
                
                    Azithromycin
                
            , 
                
                    Azithromycin
                
             💬
 | - | - | [1]  84 84 💬
 | 
| 716 | Rifaximin | [1]  Rifaximin Rifaximin | [1]  Rifaximin 
                
                    Rifaximin
                
             💬
 | - | - | [8]  6 6, 65, 93, 96, 97, 99, 296, 299 💬
 | 
| 717 | Rifaximin 550 MG | [1]  Rifaximin Rifaximin | [1]  Rifaximin 
                
                    Rifaximin
                
             💬
 | - | - | [1]  6 6 💬
 | 
| 718 | Rifaximin 550 MG Oral Tablet [XIFAXAN] | [1]  Rifaximin Rifaximin | [1]  Rifaximin 
                
                    Rifaximin
                
             💬
 | - | - | [1]  299 299 💬
 | 
| 719 | Rifaximin Delayed Release (DR) | [1]  Rifaximin Rifaximin | [1]  Rifaximin 
                
                    Rifaximin
                
             💬
 | - | - | [1]  96 96 💬
 | 
| 720 | Rifaximin delayed release 400 mg film coated tablet | [1]  Rifaximin Rifaximin | [1]  Rifaximin 
                
                    Rifaximin
                
             💬
 | - | - | [1]  96 96 💬
 | 
| 721 | Rifaximin delayed release tablets | [1]  Rifaximin Rifaximin | [1]  Rifaximin 
                
                    Rifaximin
                
             💬
 | - | - | [1]  96 96 💬
 | 
| 722 | Rifaximin EIR | [1]  Rifaximin Rifaximin | [1]  Rifaximin 
                
                    Rifaximin
                
             💬
 | - | - | [1]  96 96 💬
 | 
| 723 | Rifaximin oral tablet | [1]  Rifaximin Rifaximin | [1]  Rifaximin 
                
                    Rifaximin
                
             💬
 | - | - | [1]  99 99 💬
 | 
| 724 | Rifaximin+omeprazole+miralax | [2]  Omeprazole Omeprazole, Rifaximin | [2]  Omeprazole 
                
                    Omeprazole
                
            , 
                
                    Rifaximin
                
             💬
 | [2]  ATP4A ATP4A, ATP4B 💬
 | [4]  Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1]  96 96 💬
 | 
| 725 | Rifaximin-EIR | [1]  Rifaximin Rifaximin | [1]  Rifaximin 
                
                    Rifaximin
                
             💬
 | - | - | [1]  96 96 💬
 | 
| 726 | RIFAXIMINA | [1]  Rifaximin Rifaximin | [1]  Rifaximin 
                
                    Rifaximin
                
             💬
 | - | - | [1]  96 96 💬
 | 
| 727 | Rigerimod | - | - | - | - | [1]  49 49 💬
 | 
| 728 | Rigosertib | [1]  Rigosertib Rigosertib | [1]  Rigosertib 
                
                    Rigosertib
                
             💬
 | [1]  PLK1 PLK1 💬
 | [4]  Cell cycle Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [1]  36 36 💬
 | 
| 729 | Rigosertib Oral Capsules / Rigosertib Intravenous | [1]  Rigosertib Rigosertib | [1]  Rigosertib 
                
                    Rigosertib
                
             💬
 | [1]  PLK1 PLK1 💬
 | [4]  Cell cycle Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [1]  36 36 💬
 | 
| 730 | Rigosertib Sodium | [1]  Rigosertib Rigosertib | [1]  Rigosertib 
                
                    Rigosertib
                
             💬
 | [1]  PLK1 PLK1 💬
 | [4]  Cell cycle Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | [1]  36 36 💬
 | 
| 731 | RIL-1RA | - | - | - | - | [1]  107 107 💬
 | 
| 732 | Rilmenidine | [1]  Rilmenidine Rilmenidine | [1]  Rilmenidine 
                
                    Rilmenidine
                
             💬
 | [3]  ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
 | [2]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1]  8 8 💬
 | 
| 733 | Rilonacept | [1]  Rilonacept Rilonacept | [1]  Rilonacept 
                
                    Rilonacept
                
             💬
 | [2]  IL1A IL1A, IL1B 💬
 | [45]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [4]  51 51, 106, 107, 266 💬
 | 
| 734 | Rilonacept (IL-1 Trap) | [1]  Rilonacept Rilonacept | [1]  Rilonacept 
                
                    Rilonacept
                
             💬
 | [2]  IL1A IL1A, IL1B 💬
 | [45]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1]  107 107 💬
 | 
| 735 | Rilonacept 160 mg | [1]  Rilonacept Rilonacept | [1]  Rilonacept 
                
                    Rilonacept
                
             💬
 | [2]  IL1A IL1A, IL1B 💬
 | [45]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1]  106 106 💬
 | 
| 736 | Rilpivirine | [1]  Rilpivirine Rilpivirine | [1]  Rilpivirine 
                
                    Rilpivirine
                
             💬
 | - | - | [1]  256 256 💬
 | 
| 737 | Rilpivirine (RPV) tablet | [1]  Rilpivirine Rilpivirine | [1]  Rilpivirine 
                
                    Rilpivirine
                
             💬
 | - | - | [1]  256 256 💬
 | 
| 738 | Rilpivirine - Injectable Suspension (RPV LA) | [1]  Rilpivirine Rilpivirine | [1]  Rilpivirine 
                
                    Rilpivirine
                
             💬
 | - | - | [1]  256 256 💬
 | 
| 739 | RILUTEK | [1]  Riluzole Riluzole | [1]  Riluzole 
                
                    Riluzole
                
             💬
 | [14]  GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
 | [23]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [3]  2 2, 13, 203 💬
 | 
| 740 | Rilutek 50 mg film-coated tablets | [1]  Riluzole Riluzole | [1]  Riluzole 
                
                    Riluzole
                
             💬
 | [14]  GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
 | [23]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1]  2 2 💬
 | 
| 741 | RILUTEK 50 mg, film-coated tablets | [1]  Riluzole Riluzole | [1]  Riluzole 
                
                    Riluzole
                
             💬
 | [14]  GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
 | [23]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1]  2 2 💬
 | 
| 742 | RILUZOLE | [1]  Riluzole Riluzole | [1]  Riluzole 
                
                    Riluzole
                
             💬
 | [14]  GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
 | [23]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [9]  2 2, 3, 5, 8, 13, 17, 18, 203, 206 💬
 | 
| 743 | Riluzole (100 mg) | [1]  Riluzole Riluzole | [1]  Riluzole 
                
                    Riluzole
                
             💬
 | [14]  GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
 | [23]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1]  2 2 💬
 | 
| 744 | Riluzole 100mg/day | [1]  Riluzole Riluzole | [1]  Riluzole 
                
                    Riluzole
                
             💬
 | [14]  GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
 | [23]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1]  2 2 💬
 | 
| 745 | Riluzole 50 MG | [1]  Riluzole Riluzole | [1]  Riluzole 
                
                    Riluzole
                
             💬
 | [14]  GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
 | [23]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1]  2 2 💬
 | 
| 746 | Riluzole 50 MG (Part B) | [1]  Riluzole Riluzole | [1]  Riluzole 
                
                    Riluzole
                
             💬
 | [14]  GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
 | [23]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1]  2 2 💬
 | 
| 747 | Riluzole Oral Soluble Film | [1]  Riluzole Riluzole | [1]  Riluzole 
                
                    Riluzole
                
             💬
 | [14]  GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
 | [23]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1]  2 2 💬
 | 
| 748 | Riluzole Oral Soluble film (ROSF) 50 mg | [1]  Riluzole Riluzole | [1]  Riluzole 
                
                    Riluzole
                
             💬
 | [14]  GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
 | [23]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1]  2 2 💬
 | 
| 749 | Riluzole PMCS | [1]  Riluzole Riluzole | [1]  Riluzole 
                
                    Riluzole
                
             💬
 | [14]  GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
 | [23]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1]  18 18 💬
 | 
| 750 | Riluzole tablet | [1]  Riluzole Riluzole | [1]  Riluzole 
                
                    Riluzole
                
             💬
 | [14]  GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
 | [23]  Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | [1]  2 2 💬
 | 
| 751 | RILUZOLO | - | - | - | - | [3]  2 2, 18, 114 💬
 | 
| 752 | RILUZOLO TEVA - 50 MG COMPRESSE RIVESTITE CON FILM 90 COMPRESSE IN BLISTER AL/PVC | - | - | - | - | [1]  114 114 💬
 | 
| 753 | Rilzabrutinib | - | - | - | - | [2]  61 61, 300 💬
 | 
| 754 | Rilzabrutinib Oral Tablet | - | - | - | - | [1]  35 35 💬
 | 
| 755 | Rimacalib | [1]  Rimacalib Rimacalib | - | - | - | [1]  46 46 💬
 | 
| 756 | Rimactan | - | - | - | - | [1]  299 299 💬
 | 
| 757 | Rimeporide | [1]  Rimeporide Rimeporide | - | - | - | [1]  113 113 💬
 | 
| 758 | Rimiducid | [1]  Rimiducid Rimiducid | [1]  Rimiducid 
                
                    Rimiducid
                
             💬
 | [1]  CASP9 CASP9 💬
 | [35]  Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬 | [6]  19 19, 60, 65, 284, 285, 326 💬
 | 
| 759 | Rimonabant | [1]  Rimonabant Rimonabant | [1]  Rimonabant 
                
                    Rimonabant
                
             💬
 | [1]  CNR1 CNR1 💬
 | [4]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1]  193 193 💬
 | 
| 760 | RIMSO 50 | - | - | - | - | [1]  226 226 💬
 | 
| 761 | Ringer lactate | - | - | - | - | [1]  51 51 💬
 | 
| 762 | Rinvoq | [1]  Upadacitinib Upadacitinib | [1]  Upadacitinib 
                
                    Upadacitinib
                
             💬
 | [1]  JAK1 JAK1 💬
 | [27]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1]  271 271 💬
 | 
| 763 | Riocigu | - | - | - | - | [1]  51 51 💬
 | 
| 764 | RIOCIGUAT | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [6]  51 51, 84, 86, 88, 225, 299 💬
 | 
| 765 | Riociguat (Adempas, BAY63-2521) | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [4]  51 51, 86, 88, 299 💬
 | 
| 766 | Riociguat (BAY63-2521) | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 767 | Riociguat coated tablet 0.5 mg | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  51 51 💬
 | 
| 768 | Riociguat coated tablet 1.0 mg | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  51 51 💬
 | 
| 769 | Riociguat coated tablet 1.5 mg | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  51 51 💬
 | 
| 770 | Riociguat coated tablet 2.0 mg | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  51 51 💬
 | 
| 771 | Riociguat coated tablet 2.5 m | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  51 51 💬
 | 
| 772 | Riociguat coated tablet 2.5 mg | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  51 51 💬
 | 
| 773 | Riociguat granules 0.3% for oral application | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 774 | Riociguat Oral Product | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 775 | Riociguat Oral Tablet | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [3]  51 51, 86, 88 💬
 | 
| 776 | Riociguat Pill | [1]  Riociguat Riociguat | [1]  Riociguat 
                
                    Riociguat
                
             💬
 | [3]  GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
 | [11]  Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 777 | RIPK1 inhibitor | - | - | - | - | [1]  13 13 💬
 | 
| 778 | RIQUENT | - | - | - | - | [1]  49 49 💬
 | 
| 779 | Risankizumab | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [4]  37 37, 96, 97, 271 💬
 | 
| 780 | Risankizumab (Genetical Recombination) | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1]  97 97 💬
 | 
| 781 | Risankizumab 10 mg/ml | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1]  96 96 💬
 | 
| 782 | Risankizumab 180 mg SC | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1]  96 96 💬
 | 
| 783 | Risankizumab 600 mg IV | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1]  96 96 💬
 | 
| 784 | Risankizumab 90 mg/ml | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1]  96 96 💬
 | 
| 785 | Risankizumab IV | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2]  96 96, 97 💬
 | 
| 786 | Risankizumab On-Body Injector (OBI) | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1]  96 96 💬
 | 
| 787 | Risankizumab SC | [1]  Risankizumab Risankizumab | [1]  Risankizumab 
                
                    Risankizumab
                
             💬
 | [1]  IL23A IL23A 💬
 | [9]  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [2]  96 96, 97 💬
 | 
| 788 | Risdiplam | [1]  Risdiplam Risdiplam | [1]  Risdiplam 
                
                    Risdiplam
                
             💬
 | [1]  SMN2 SMN2 💬
 | [1]  Nucleocytoplasmic transport Nucleocytoplasmic transport 💬 | [1]  3 3 💬
 | 
| 789 | Risedronate | [1]  Risedronic acid Risedronic acid | [1]  Risedronic acid 
                
                    Risedronic acid
                
             💬
 | [1]  FDPS FDPS 💬
 | [4]  Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [7]  46 46, 50, 66, 96, 107, 113, 274 💬
 | 
| 790 | Risedronate Oral Tablet | [1]  Risedronic acid Risedronic acid | [1]  Risedronic acid 
                
                    Risedronic acid
                
             💬
 | [1]  FDPS FDPS 💬
 | [4]  Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1]  274 274 💬
 | 
| 791 | RISEDRONATE SODIUM | [1]  Risedronic acid Risedronic acid | [1]  Risedronic acid 
                
                    Risedronic acid
                
             💬
 | [1]  FDPS FDPS 💬
 | [4]  Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [4]  50 50, 107, 113, 274 💬
 | 
| 792 | Risedronate sodium (Actonel) | [1]  Risedronic acid Risedronic acid | [1]  Risedronic acid 
                
                    Risedronic acid
                
             💬
 | [1]  FDPS FDPS 💬
 | [4]  Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1]  274 274 💬
 | 
| 793 | Risedronate sodium 2.5mg | [1]  Risedronic acid Risedronic acid | [1]  Risedronic acid 
                
                    Risedronic acid
                
             💬
 | [1]  FDPS FDPS 💬
 | [4]  Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1]  274 274 💬
 | 
| 794 | Risedronate sodium 5mg | [1]  Risedronic acid Risedronic acid | [1]  Risedronic acid 
                
                    Risedronic acid
                
             💬
 | [1]  FDPS FDPS 💬
 | [4]  Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1]  274 274 💬
 | 
| 795 | Risedronato sódico 2.5mg | - | - | - | - | [1]  274 274 💬
 | 
| 796 | Risedronato sódico 5mg | - | - | - | - | [1]  274 274 💬
 | 
| 797 | Risedronic acid | [1]  Risedronic acid Risedronic acid | [1]  Risedronic acid 
                
                    Risedronic acid
                
             💬
 | [1]  FDPS FDPS 💬
 | [4]  Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [3]  93 93, 95, 274 💬
 | 
| 798 | Risperdal | - | - | - | - | [1]  203 203 💬
 | 
| 799 | Risperidone | [1]  Risperidone Risperidone | [1]  Risperidone 
                
                    Risperidone
                
             💬
 | [2]  DRD2 DRD2, HTR2A 💬
 | [11]  Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | [5]  8 8, 156, 179, 187, 206 💬
 | 
| 800 | Risperidone 1Mg Tab | [1]  Risperidone Risperidone | [1]  Risperidone 
                
                    Risperidone
                
             💬
 | [2]  DRD2 DRD2, HTR2A 💬
 | [11]  Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | [1]  8 8 💬
 | 
| 801 | RIST4721 | - | - | - | - | [1]  266 266 💬
 | 
| 802 | Ritalin | [1]  Methylphenidate Methylphenidate | [1]  Methylphenidate 
                
                    Methylphenidate
                
             💬
 | [2]  SLC6A2 SLC6A2, SLC6A3 💬
 | [7]  Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [2]  6 6, 13 💬
 | 
| 803 | Ritalin LA 20mg capsules | [1]  Methylphenidate Methylphenidate | [1]  Methylphenidate 
                
                    Methylphenidate
                
             💬
 | [2]  SLC6A2 SLC6A2, SLC6A3 💬
 | [7]  Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1]  13 13 💬
 | 
| 804 | Ritalin LA 30mg capsules | [1]  Methylphenidate Methylphenidate | [1]  Methylphenidate 
                
                    Methylphenidate
                
             💬
 | [2]  SLC6A2 SLC6A2, SLC6A3 💬
 | [7]  Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1]  13 13 💬
 | 
| 805 | Ritalin LA 40mg capsules | [1]  Methylphenidate Methylphenidate | [1]  Methylphenidate 
                
                    Methylphenidate
                
             💬
 | [2]  SLC6A2 SLC6A2, SLC6A3 💬
 | [7]  Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1]  13 13 💬
 | 
| 806 | Ritlecitinib | - | - | - | - | [1]  97 97 💬
 | 
| 807 | Ritlecitinib 10 mg | - | - | - | - | [1]  97 97 💬
 | 
| 808 | Ritlecitinib 5 mg | - | - | - | - | [1]  97 97 💬
 | 
| 809 | Ritlecitinib 50 mg | - | - | - | - | [2]  96 96, 97 💬
 | 
| 810 | Ritlecitinib 50mg | - | - | - | - | [1]  96 96 💬
 | 
| 811 | Ritlecitinib/JAK 3 | - | - | - | - | [1]  46 46 💬
 | 
| 812 | Ritonavir | [1]  Ritonavir Ritonavir | [1]  Ritonavir 
                
                    Ritonavir
                
             💬
 | - | - | [3]  2 2, 86, 265 💬
 | 
| 813 | Ritonavir (Norvir) | [1]  Ritonavir Ritonavir | [1]  Ritonavir 
                
                    Ritonavir
                
             💬
 | - | - | [1]  265 265 💬
 | 
| 814 | Ritumax® | - | - | - | - | [1]  46 46 💬
 | 
| 815 | Rituxan | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [4]  46 46, 60, 256, 288 💬
 | 
| 816 | Rituxan (INN: Rituximab), brand name in the United States | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 817 | Rituxan (INN: Rituximab), brand name in the US | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 818 | Rituxan (rituximab) | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  49 49 💬
 | 
| 819 | Rituxan (US, Canada, Japan), MabThera (rest of the world) | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 820 | Rituxan (US, Canada, Japan), MabThera (rest of world) | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  53 53 💬
 | 
| 821 | Rituxan® | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 822 | Rituxan® (rituximab) | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 823 | RITUXIMAB | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [48]  11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
 | 
| 824 | Rituximab (anti-CD20) | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  53 53 💬
 | 
| 825 | Rituximab (Arm A) | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2]  43 43, 44 💬
 | 
| 826 | Rituximab (Arm B) | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2]  43 43, 44 💬
 | 
| 827 | Rituximab (EU) | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 828 | Rituximab (genetical recombination) | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  14 14 💬
 | 
| 829 | Rituximab (MABTHERA® or RITUXAN®). | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2]  35 35, 61 💬
 | 
| 830 | Rituximab (Mabthera®) | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  61 61 💬
 | 
| 831 | Rituximab (Rituxan) | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  11 11 💬
 | 
| 832 | Rituximab (RTX) and Azathioprine (AZA) | [2]  Azathioprine Azathioprine, Rituximab | [2]  Azathioprine 
                
                    Azathioprine
                
            , 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  65 65 💬
 | 
| 833 | Rituximab (US) | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 834 | Rituximab - MabThera | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 835 | Rituximab 1g IV | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  162 162 💬
 | 
| 836 | Rituximab [MabThera/Rituxan] | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2]  46 46, 63 💬
 | 
| 837 | Rituximab [MabThera] | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 838 | Rituximab and Cyclophosphamide IV | [2]  Cyclophosphamide Cyclophosphamide, Rituximab | [3]  Cyclophosphamide 
                
                    Cyclophosphamide
                
            , 
                
                    Rituximab
                
            , 
                
                    Cyclophosphamide
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  35 35 💬
 | 
| 839 | Rituximab and Hyaluronidase Human | [2]  Hyaluronidase Hyaluronidase, Rituximab | [4]  Rituximab 
                
                    Rituximab
                
            , 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  331 331 💬
 | 
| 840 | Rituximab combined with Omalizumab | [2]  Omalizumab Omalizumab, Rituximab | [2]  Rituximab 
                
                    Rituximab
                
            , 
                
                    Omalizumab
                
             💬
 | [2]  FCER1A FCER1A, MS4A1 💬
 | [5]  Asthma Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | [1]  162 162 💬
 | 
| 841 | Rituximab combined with tacrolimus induction + rituximab maintenance | [2]  Rituximab Rituximab, Tacrolimus | [3]  Tacrolimus 
                
                    Tacrolimus
                
            , 
                
                    Rituximab
                
            , 
                
                    Tacrolimus
                
             💬
 | [6]  MS4A1 MS4A1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [34]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1]  222 222 💬
 | 
| 842 | Rituximab combined with tacrolimus induction + tacrolimus maintenance | [2]  Rituximab Rituximab, Tacrolimus | [3]  Tacrolimus 
                
                    Tacrolimus
                
            , 
                
                    Rituximab
                
            , 
                
                    Tacrolimus
                
             💬
 | [6]  MS4A1 MS4A1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
 | [34]  Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1]  222 222 💬
 | 
| 843 | Rituximab Infusion | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2]  13 13, 222 💬
 | 
| 844 | Rituximab IT | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  13 13 💬
 | 
| 845 | Rituximab IV | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  13 13 💬
 | 
| 846 | Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  13 13 💬
 | 
| 847 | Rituximab MabThera | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 848 | Rituximab, Cyclophosphamide, and Corticosteroids | [2]  Cyclophosphamide Cyclophosphamide, Rituximab | [3]  Cyclophosphamide 
                
                    Cyclophosphamide
                
            , 
                
                    Rituximab
                
            , 
                
                    Cyclophosphamide
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  222 222 💬
 | 
| 849 | Rituximab, Mabthera | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  53 53 💬
 | 
| 850 | Rituximab, MTX, folic acid | [2]  Folic acid Folic acid, Rituximab | [2]  Folic acid 
                
                    Folic acid
                
            , 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 851 | Rituximab, observational study amon patients with active RA | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 852 | Rituximab-EU+ Rituximab-Pfizer x 2 Courses | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 853 | Rituximab-Pfizer | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 854 | Rituximab-Pfizer (PF-05280586) x 3 courses | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 855 | Rituximab-US + Rituximab-Pfizer x 2 Courses | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 856 | Rituximab/ Mabthera | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  271 271 💬
 | 
| 857 | RIV-TDS 13.3 mg/24 h | - | - | - | - | [1]  6 6 💬
 | 
| 858 | Rivaroxaban | [1]  Rivaroxaban Rivaroxaban | [1]  Rivaroxaban 
                
                    Rivaroxaban
                
             💬
 | [1]  F10 F10 💬
 | [1]  Complement and coagulation cascades Complement and coagulation cascades 💬 | [4]  46 46, 49, 91, 210 💬
 | 
| 859 | Rivaroxaban 20 mg | [1]  Rivaroxaban Rivaroxaban | [1]  Rivaroxaban 
                
                    Rivaroxaban
                
             💬
 | [1]  F10 F10 💬
 | [1]  Complement and coagulation cascades Complement and coagulation cascades 💬 | [1]  91 91 💬
 | 
| 860 | Rivastigmin | - | - | - | - | [1]  13 13 💬
 | 
| 861 | Rivastigmin Luye Transdermal Patches - 4.6mg/24h | - | - | - | - | [1]  6 6 💬
 | 
| 862 | RIVASTIGMINE | [1]  Rivastigmine Rivastigmine | [1]  Rivastigmine 
                
                    Rivastigmine
                
             💬
 | [1]  ACHE ACHE 💬
 | [2]  Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [3]  5 5, 6, 13 💬
 | 
| 863 | Rivastigmine capsule | [1]  Rivastigmine Rivastigmine | [1]  Rivastigmine 
                
                    Rivastigmine
                
             💬
 | [1]  ACHE ACHE 💬
 | [2]  Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1]  6 6 💬
 | 
| 864 | Rivastigmine CF | [1]  Rivastigmine Rivastigmine | [1]  Rivastigmine 
                
                    Rivastigmine
                
             💬
 | [1]  ACHE ACHE 💬
 | [2]  Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1]  6 6 💬
 | 
| 865 | Rivastigmine Luye Transdermal Patch- 9.5mg/24h | [1]  Rivastigmine Rivastigmine | [1]  Rivastigmine 
                
                    Rivastigmine
                
             💬
 | [1]  ACHE ACHE 💬
 | [2]  Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1]  6 6 💬
 | 
| 866 | Rivastigmine Patch 9.5 cm2 | [1]  Rivastigmine Rivastigmine | [1]  Rivastigmine 
                
                    Rivastigmine
                
             💬
 | [1]  ACHE ACHE 💬
 | [2]  Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1]  6 6 💬
 | 
| 867 | Rivastigmine transdermal patch | [1]  Rivastigmine Rivastigmine | [1]  Rivastigmine 
                
                    Rivastigmine
                
             💬
 | [1]  ACHE ACHE 💬
 | [2]  Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [2]  6 6, 13 💬
 | 
| 868 | Rivastigmine Transdermal System | [1]  Rivastigmine Rivastigmine | [1]  Rivastigmine 
                
                    Rivastigmine
                
             💬
 | [1]  ACHE ACHE 💬
 | [2]  Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1]  6 6 💬
 | 
| 869 | Rivastigmine transdermal system 13.3 mg/24 h | [1]  Rivastigmine Rivastigmine | [1]  Rivastigmine 
                
                    Rivastigmine
                
             💬
 | [1]  ACHE ACHE 💬
 | [2]  Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1]  6 6 💬
 | 
| 870 | Rivenprost | [1]  Rivenprost Rivenprost | - | - | - | [1]  97 97 💬
 | 
| 871 | Rivenprost (drug) | [1]  Rivenprost Rivenprost | - | - | - | [1]  97 97 💬
 | 
| 872 | Rivogenlecleucel | - | - | - | - | [4]  19 19, 60, 285, 326 💬
 | 
| 873 | Rivogenleucleucel | - | - | - | - | [3]  60 60, 285, 326 💬
 | 
| 874 | Rixathon | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  46 46 💬
 | 
| 875 | RIXATHON 500 mg | - | - | - | - | [1]  85 85 💬
 | 
| 876 | RIXATHON 500mg | - | - | - | - | [1]  43 43 💬
 | 
| 877 | Rizankisumab | - | - | - | - | [1]  96 96 💬
 | 
| 878 | Rizankizumab | - | - | - | - | [1]  96 96 💬
 | 
| 879 | RM-131 | - | - | - | - | [1]  6 6 💬
 | 
| 880 | RM-493 | - | - | - | - | [2]  193 193, 202 💬
 | 
| 881 | RN624, RI624 | - | - | - | - | [1]  226 226 💬
 | 
| 882 | RNA antisense oligonucleotide for intravitreal injection | - | - | - | - | [2]  90 90, 303 💬
 | 
| 883 | RNA extraction | - | - | - | - | [1]  113 113 💬
 | 
| 884 | RNA Sequencing | - | - | - | - | [1]  84 84 💬
 | 
| 885 | RNF | - | - | - | - | [1]  13 13 💬
 | 
| 886 | RNL-Vascostem® | - | - | - | - | [1]  47 47 💬
 | 
| 887 | RNS60 | - | - | - | - | [2]  2 2, 13 💬
 | 
| 888 | RNS60 125 ml | - | - | - | - | [1]  13 13 💬
 | 
| 889 | RNS60 250 ml | - | - | - | - | [1]  13 13 💬
 | 
| 890 | RO | - | - | - | - | [1]  6 6 💬
 | 
| 891 | Ro 001-9265 | - | - | - | - | [1]  41 41 💬
 | 
| 892 | Ro 001-9265/F02 | - | - | - | - | [1]  41 41 💬
 | 
| 893 | RO 001-9265/F02-01 | - | - | - | - | [1]  46 46 💬
 | 
| 894 | Ro 001-9265/F03 | - | - | - | - | [1]  41 41 💬
 | 
| 895 | Ro 001-9265/F04 | - | - | - | - | [1]  41 41 💬
 | 
| 896 | Ro 002-9893/F02 | - | - | - | - | [1]  46 46 💬
 | 
| 897 | Ro 106-1443 | - | - | - | - | [1]  49 49 💬
 | 
| 898 | Ro 45-2294 | - | - | - | - | [1]  46 46 💬
 | 
| 899 | Ro 47-0203 | - | - | - | - | [4]  51 51, 85, 86, 88 💬
 | 
| 900 | Ro 47-0203 / ACT-050088 | - | - | - | - | [1]  86 86 💬
 | 
| 901 | Ro 48-77533 | - | - | - | - | [1]  46 46 💬
 | 
| 902 | Ro 487-533/F01 | - | - | - | - | [1]  271 271 💬
 | 
| 903 | Ro 487-5733/F01 | - | - | - | - | [1]  271 271 💬
 | 
| 904 | RO 487-7533 | - | - | - | - | [1]  46 46 💬
 | 
| 905 | Ro 487-7533/F01 | - | - | - | - | [3]  46 46, 107, 271 💬
 | 
| 906 | Ro 487-7533/F10 | - | - | - | - | [2]  46 46, 107 💬
 | 
| 907 | Ro 487-7533/F10-02 | - | - | - | - | [1]  46 46 💬
 | 
| 908 | Ro 487-7533/F10-04 | - | - | - | - | [4]  41 41, 46, 51, 107 💬
 | 
| 909 | Ro 491-7523/F18 | - | - | - | - | [1]  206 206 💬
 | 
| 910 | Ro 491-7523/F19 | - | - | - | - | [1]  206 206 💬
 | 
| 911 | RO 496-4913 | - | - | - | - | [2]  46 46, 49 💬
 | 
| 912 | Ro 496-4913/F03 | - | - | - | - | [2]  13 13, 46 💬
 | 
| 913 | Ro 496-4913/F07 | - | - | - | - | [1]  13 13 💬
 | 
| 914 | Ro 533-3787/F01- 06 | - | - | - | - | [1]  13 13 💬
 | 
| 915 | Ro 533-3787/F01-06 | - | - | - | - | [1]  11 11 💬
 | 
| 916 | Ro 549-0261/F04 | - | - | - | - | [1]  97 97 💬
 | 
| 917 | Ro 549-0261/F04-02 | - | - | - | - | [1]  96 96 💬
 | 
| 918 | Ro 549-0261/F08-02 | - | - | - | - | [1]  96 96 💬
 | 
| 919 | RO 551-6922 | - | - | - | - | [1]  46 46 💬
 | 
| 920 | Ro 723-4292/F02 | - | - | - | - | [1]  8 8 💬
 | 
| 921 | Ro Actemra | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  46 46 💬
 | 
| 922 | Ro-47-0203 | - | - | - | - | [1]  86 86 💬
 | 
| 923 | Ro-47-0203/029 | - | - | - | - | [1]  86 86 💬
 | 
| 924 | RO-496-4913 | - | - | - | - | [1]  46 46 💬
 | 
| 925 | Ro-Actemra | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2]  46 46, 107 💬
 | 
| 926 | RO001-9265/F04 | - | - | - | - | [1]  46 46 💬
 | 
| 927 | RO0029893 | - | - | - | - | [1]  46 46 💬
 | 
| 928 | RO0220912 | - | - | - | - | [1]  85 85 💬
 | 
| 929 | RO0280296 | - | - | - | - | [1]  85 85 💬
 | 
| 930 | RO045-2294 | - | - | - | - | [1]  46 46 💬
 | 
| 931 | RO0452294/V01 | - | - | - | - | [2]  43 43, 44 💬
 | 
| 932 | RO0452294/V02 | - | - | - | - | [3]  35 35, 43, 44 💬
 | 
| 933 | RO0485337 | - | - | - | - | [1]  222 222 💬
 | 
| 934 | RO04877533 | - | - | - | - | [1]  46 46 💬
 | 
| 935 | RO04877533/F05/F04 | - | - | - | - | [1]  46 46 💬
 | 
| 936 | RO0506997 | - | - | - | - | [2]  13 13, 46 💬
 | 
| 937 | Ro106-1443 | - | - | - | - | [1]  43 43 💬
 | 
| 938 | RO1061443/F02 | - | - | - | - | [1]  35 35 💬
 | 
| 939 | RO3300074 | - | - | - | - | [1]  231 231 💬
 | 
| 940 | RO4402257 | - | - | - | - | [1]  46 46 💬
 | 
| 941 | Ro45-2294 | - | - | - | - | [1]  271 271 💬
 | 
| 942 | RO452294/V02 | - | - | - | - | [1]  46 46 💬
 | 
| 943 | Ro47-0203 | - | - | - | - | [1]  86 86 💬
 | 
| 944 | Ro47-0203 / ACT-050088 | - | - | - | - | [2]  51 51, 86 💬
 | 
| 945 | Ro487-7533 | - | - | - | - | [1]  46 46 💬
 | 
| 946 | RO487-7533/F01-F05 | - | - | - | - | [1]  46 46 💬
 | 
| 947 | RO487-7533/F10-04 | - | - | - | - | [2]  46 46, 51 💬
 | 
| 948 | RO4877533 | - | - | - | - | [2]  46 46, 107 💬
 | 
| 949 | RO4877533 (TCZ) | - | - | - | - | [2]  46 46, 107 💬
 | 
| 950 | RO4877533/F01 | - | - | - | - | [1]  46 46 💬
 | 
| 951 | RO4877533/F04-F05 | - | - | - | - | [1]  46 46 💬
 | 
| 952 | RO4917523 | - | - | - | - | [1]  206 206 💬
 | 
| 953 | RO4917523 0.5 mg | - | - | - | - | [1]  206 206 💬
 | 
| 954 | RO4917523 1.5 mg | - | - | - | - | [1]  206 206 💬
 | 
| 955 | RO496-4913 | - | - | - | - | [1]  46 46 💬
 | 
| 956 | RO4964913 | - | - | - | - | [1]  13 13 💬
 | 
| 957 | RO4964913 F07 | - | - | - | - | [1]  13 13 💬
 | 
| 958 | RO4964913/F03 | - | - | - | - | [1]  13 13 💬
 | 
| 959 | RO4964913/F07 | - | - | - | - | [1]  13 13 💬
 | 
| 960 | RO4964913/F07-01 | - | - | - | - | [1]  13 13 💬
 | 
| 961 | RO5072759 | - | - | - | - | [1]  222 222 💬
 | 
| 962 | RO5333787 | - | - | - | - | [2]  11 11, 13 💬
 | 
| 963 | RO545-9072/F03 | - | - | - | - | [1]  53 53 💬
 | 
| 964 | RO5459072 | - | - | - | - | [1]  53 53 💬
 | 
| 965 | Ro549-0261/F04-02 | - | - | - | - | [1]  96 96 💬
 | 
| 966 | RO5490255 | - | - | - | - | [1]  85 85 💬
 | 
| 967 | RO5490255/F01-02 | - | - | - | - | [1]  85 85 💬
 | 
| 968 | RO5490261 / F02 | - | - | - | - | [1]  97 97 💬
 | 
| 969 | RO5490261/F02 | - | - | - | - | [1]  97 97 💬
 | 
| 970 | RO5490261/F04-02 | - | - | - | - | [1]  97 97 💬
 | 
| 971 | RO5534262 EMICIZUMAB | [1]  Emicizumab Emicizumab | [1]  Emicizumab 
                
                    Emicizumab
                
             💬
 | [2]  F10 F10, F9 💬
 | [1]  Complement and coagulation cascades Complement and coagulation cascades 💬 | [1]  288 288 💬
 | 
| 972 | RO6885247 | - | - | - | - | [1]  3 3 💬
 | 
| 973 | RO6885247/F02 | - | - | - | - | [1]  3 3 💬
 | 
| 974 | RO6885247/F03 | - | - | - | - | [1]  3 3 💬
 | 
| 975 | RO7010939 | - | - | - | - | [2]  13 13, 46 💬
 | 
| 976 | RO7010939/F13 | - | - | - | - | [1]  49 49 💬
 | 
| 977 | RO7021610 | - | - | - | - | [1]  97 97 💬
 | 
| 978 | RO7034067 | - | - | - | - | [1]  3 3 💬
 | 
| 979 | RO7034067 / F12 | - | - | - | - | [1]  3 3 💬
 | 
| 980 | RO7034067 / F13 | - | - | - | - | [1]  3 3 💬
 | 
| 981 | RO7034067/F06 + solvente (RO | - | - | - | - | [1]  3 3 💬
 | 
| 982 | RO7034067/F06 with solvent (RO7034067/F08) | - | - | - | - | [1]  3 3 💬
 | 
| 983 | RO7034067/F07 + solvente (RO | - | - | - | - | [1]  3 3 💬
 | 
| 984 | RO7034067/F07 with solvent (RO7034067/F09) | - | - | - | - | [1]  3 3 💬
 | 
| 985 | RO7034067/F12 | - | - | - | - | [1]  3 3 💬
 | 
| 986 | RO7034067/F13 | - | - | - | - | [1]  3 3 💬
 | 
| 987 | RO7046015 | - | - | - | - | [1]  6 6 💬
 | 
| 988 | RO7046015/PRASINEZUMAB | [1]  Prasinezumab Prasinezumab | [1]  Prasinezumab 
                
                    Prasinezumab
                
             💬
 | [1]  SNCA SNCA 💬
 | [3]  Alzheimer disease Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | [1]  6 6 💬
 | 
| 989 | RO7049665 | - | - | - | - | [2]  95 95, 97 💬
 | 
| 990 | RO7049665/IgG-IL2/ IgG-IL2ND2 | - | - | - | - | [1]  95 95 💬
 | 
| 991 | RO7090919 | - | - | - | - | [1]  3 3 💬
 | 
| 992 | RO7112689 | - | - | - | - | [1]  62 62 💬
 | 
| 993 | RO7112689/F01 | - | - | - | - | [1]  62 62 💬
 | 
| 994 | RO7112689/F03-01 | - | - | - | - | [2]  62 62, 109 💬
 | 
| 995 | RO7112689/F03-10 | - | - | - | - | [2]  62 62, 109 💬
 | 
| 996 | RO7121932 | - | - | - | - | [1]  13 13 💬
 | 
| 997 | RO7123520 | - | - | - | - | [1]  46 46 💬
 | 
| 998 | RO7123520/F03-01 | - | - | - | - | [1]  46 46 💬
 | 
| 999 | RO7204239 | - | - | - | - | [2]  3 3, 113 💬
 | 
| 1000 | RO7204239/F01-01 | - | - | - | - | [1]  3 3 💬
 | 
| 1001 | RO7234292 | - | - | - | - | [1]  8 8 💬
 | 
| 1002 | RO7234292 (RG6042) | - | - | - | - | [1]  8 8 💬
 | 
| 1003 | RO7239361 | - | - | - | - | [1]  113 113 💬
 | 
| 1004 | RO7239361 (BMS-986089) | - | - | - | - | [1]  113 113 💬
 | 
| 1005 | RO7239361 Injections, 15 mg/Syringe (21.4 mg/mL) | - | - | - | - | [1]  113 113 💬
 | 
| 1006 | RO7239361 Injections, 35 mg/Syringe (50 mg/mL) | - | - | - | - | [1]  113 113 💬
 | 
| 1007 | RO7239361 Injections, 50 mg/Syringe (71.4 mg/mL) | - | - | - | - | [1]  113 113 💬
 | 
| 1008 | RO7239361 Injections, 7.5 mg/Syringe (10.7 mg/mL) | - | - | - | - | [1]  113 113 💬
 | 
| 1009 | RO7246311 | - | - | - | - | [1]  97 97 💬
 | 
| 1010 | RO7248824 | - | - | - | - | [1]  201 201 💬
 | 
| 1011 | RO7248824/F02-01 | - | - | - | - | [1]  201 201 💬
 | 
| 1012 | RO7248824/F03-01 (Diluent for RO7248824/F02-01 | - | - | - | - | [1]  201 201 💬
 | 
| 1013 | RO7303509 | - | - | - | - | [1]  51 51 💬
 | 
| 1014 | RO7490677 | - | - | - | - | [1]  85 85 💬
 | 
| 1015 | RO7490677 160 mg/8 ml | - | - | - | - | [1]  85 85 💬
 | 
| 1016 | RO7490677 160 mg/8mL | - | - | - | - | [1]  85 85 💬
 | 
| 1017 | RO7490677 160mg/8mL | - | - | - | - | [1]  85 85 💬
 | 
| 1018 | RO7490677 320 mg/16 ml (2nd generation) | - | - | - | - | [1]  85 85 💬
 | 
| 1019 | RO7490677 320mg/16mL (1st generation) | - | - | - | - | [1]  85 85 💬
 | 
| 1020 | RO7490677 320mg/16mL (2nd generation) | - | - | - | - | [1]  85 85 💬
 | 
| 1021 | RO7490677/ F01-02 | - | - | - | - | [1]  85 85 💬
 | 
| 1022 | RO7490677/F01-01 | - | - | - | - | [1]  85 85 💬
 | 
| 1023 | RO7490677/F01-02 | - | - | - | - | [1]  85 85 💬
 | 
| 1024 | RO7490677/F01-03 | - | - | - | - | [1]  85 85 💬
 | 
| 1025 | RoActemra | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [11]  40 40, 41, 44, 46, 50, 51, 86, 107, 266, 271, 331 💬
 | 
| 1026 | RoActemra (R) | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  46 46 💬
 | 
| 1027 | ROACTEMRA - 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2]  46 46, 51 💬
 | 
| 1028 | ROACTEMRA - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  46 46 💬
 | 
| 1029 | RoActemra 162 mg | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2]  46 46, 51 💬
 | 
| 1030 | RoActemra 162 mg solution for injection in pre-filled syringe | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  41 41 💬
 | 
| 1031 | RoActemra 162 mg solution injectable en seringue préremplie | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  46 46 💬
 | 
| 1032 | RoActemra 162 mg soluzione iniettabile in siringa preriempita | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  50 50 💬
 | 
| 1033 | RoActemra 20 mg/ml concentrado para solución para perfusión | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  46 46 💬
 | 
| 1034 | RoActemra 20 mg/ml Concentrate for solution for infusion | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  46 46 💬
 | 
| 1035 | RoActemra 20 mg/ml concentrate for solution for infusion. | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  46 46 💬
 | 
| 1036 | ROACTEMRA 20 mg/ml, concentrado para solución para perfusión | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [3]  46 46, 107, 271 💬
 | 
| 1037 | RoActemra 20mg/ml | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  40 40 💬
 | 
| 1038 | RoActemra(R) | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  46 46 💬
 | 
| 1039 | RoActemra/Actemra (tocilizumab) | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  107 107 💬
 | 
| 1040 | RoActemra® | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2]  46 46, 271 💬
 | 
| 1041 | RoActemra® 20mg/ml Konzentrat | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  266 266 💬
 | 
| 1042 | RoActemra®EV Product Code: PRD82321 | [1]  Tocilizumab Tocilizumab | [1]  Tocilizumab 
                
                    Tocilizumab
                
             💬
 | [1]  IL6R IL6R 💬
 | [12]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1]  46 46 💬
 | 
| 1043 | RoActerma | - | - | - | - | [1]  46 46 💬
 | 
| 1044 | RoActmera | - | - | - | - | [1]  46 46 💬
 | 
| 1045 | Rob 803 | - | - | - | - | [1]  46 46 💬
 | 
| 1046 | Rob 803 (9-Chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-b] quinoxali | - | - | - | - | [1]  46 46 💬
 | 
| 1047 | Rob 803 (capsules 12.5 mg) | - | - | - | - | [1]  46 46 💬
 | 
| 1048 | Rob 803 (capsules 15 mg) | - | - | - | - | [1]  46 46 💬
 | 
| 1049 | Rob 803 (capsules 25 mg) | - | - | - | - | [1]  46 46 💬
 | 
| 1050 | Rob 803 (capsules 6.25 mg) | - | - | - | - | [1]  46 46 💬
 | 
| 1051 | Rob 803 12.5mg capsule | - | - | - | - | [1]  46 46 💬
 | 
| 1052 | Rob 803 15mg capsule | - | - | - | - | [1]  46 46 💬
 | 
| 1053 | Rob 803 25mg capsule | - | - | - | - | [1]  46 46 💬
 | 
| 1054 | Rob 803 6.25mg capsule | - | - | - | - | [1]  46 46 💬
 | 
| 1055 | Rob 803 6.5mg capsule | - | - | - | - | [1]  46 46 💬
 | 
| 1056 | Rocuronium | [1]  Rocuronium Rocuronium | - | - | - | [2]  70 70, 296 💬
 | 
| 1057 | Rocuronium Bromide | [1]  Rocuronium Rocuronium | - | - | - | [1]  70 70 💬
 | 
| 1058 | Rodatristat ethyl | - | - | - | - | [1]  86 86 💬
 | 
| 1059 | Rodatristat ethyl 300 mg tablet BID | - | - | - | - | [1]  86 86 💬
 | 
| 1060 | Rodatristat ethyl 600 mg BID | - | - | - | - | [1]  86 86 💬
 | 
| 1061 | Rofecoxib | [1]  Rofecoxib Rofecoxib | [1]  Rofecoxib 
                
                    Rofecoxib
                
             💬
 | [1]  PTGS2 PTGS2 💬
 | [22]  Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1]  46 46 💬
 | 
| 1062 | Roferon-A | [1]  Interferon alfa-2a Interferon alfa-2a | [1]  Interferon alfa-2a 
                
                    Interferon alfa-2a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  56 56 💬
 | 
| 1063 | Roferon-A 3miu | [1]  Interferon alfa-2a Interferon alfa-2a | [1]  Interferon alfa-2a 
                
                    Interferon alfa-2a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  56 56 💬
 | 
| 1064 | Roferon-A, 3miu | [1]  Interferon alfa-2a Interferon alfa-2a | [1]  Interferon alfa-2a 
                
                    Interferon alfa-2a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  56 56 💬
 | 
| 1065 | Roferon-A, 4.5miu | [1]  Interferon alfa-2a Interferon alfa-2a | [1]  Interferon alfa-2a 
                
                    Interferon alfa-2a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  56 56 💬
 | 
| 1066 | Roferon-A, 6miu | [1]  Interferon alfa-2a Interferon alfa-2a | [1]  Interferon alfa-2a 
                
                    Interferon alfa-2a
                
             💬
 | [2]  IFNAR1 IFNAR1, IFNAR2 💬
 | [18]  Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1]  56 56 💬
 | 
| 1067 | Roflumilast | [1]  Roflumilast Roflumilast | [1]  Roflumilast 
                
                    Roflumilast
                
             💬
 | [4]  PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
 | [5]  Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [4]  84 84, 97, 206, 299 💬
 | 
| 1068 | Roflumilast 500 Ug ORAL TABLET [Daliresp] | [1]  Roflumilast Roflumilast | [1]  Roflumilast 
                
                    Roflumilast
                
             💬
 | [4]  PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
 | [5]  Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1]  97 97 💬
 | 
| 1069 | Roflumilast Oral Tablet | [1]  Roflumilast Roflumilast | [1]  Roflumilast 
                
                    Roflumilast
                
             💬
 | [4]  PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
 | [5]  Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1]  299 299 💬
 | 
| 1070 | Rokan (r) Novo 120 mg | - | - | - | - | [1]  18 18 💬
 | 
| 1071 | Rolipram | [1]  Rolipram Rolipram | [1]  Rolipram 
                
                    Rolipram
                
             💬
 | [4]  PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬
 | [5]  Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [2]  8 8, 13 💬
 | 
| 1072 | Romiplostim | [1]  Romiplostim Romiplostim | [1]  Romiplostim 
                
                    Romiplostim
                
             💬
 | [1]  MPL MPL 💬
 | [2]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [4]  60 60, 63, 64, 65 💬
 | 
| 1073 | Romiplostim plus dexamethasone | [2]  Dexamethasone Dexamethasone, Romiplostim | [2]  Dexamethasone 
                
                    Dexamethasone
                
            , 
                
                    Romiplostim
                
             💬
 | [2]  MPL MPL, NR3C1 💬
 | [3]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1]  63 63 💬
 | 
| 1074 | Romiplostin | - | - | - | - | [1]  63 63 💬
 | 
| 1075 | ROMOSOZUMAB | [1]  Romosozumab Romosozumab | [1]  Romosozumab 
                
                    Romosozumab
                
             💬
 | [1]  SOST SOST 💬
 | [2]  Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬 | [1]  274 274 💬
 | 
| 1076 | Rontalizumab | [1]  Rontalizumab Rontalizumab | [1]  Rontalizumab 
                
                    Rontalizumab
                
             💬
 | [13]  IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬
 | [25]  Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1]  49 49 💬
 | 
| 1077 | ROP | - | - | - | - | [1]  6 6 💬
 | 
| 1078 | ROP+L-Dopa | [1]  Levodopa Levodopa | [1]  Levodopa 
                
                    Levodopa
                
             💬
 | [5]  DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
 | [11]  Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1079 | ROPINIROLE | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [3]  6 6, 74, 309 💬
 | 
| 1080 | Ropinirole (as hydrochloride) | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1081 | Ropinirole controlled-release (REQUIP CR) for RLS | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1082 | Ropinirole CR 2mg tablet | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1083 | Ropinirole CR 8mg tablet | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1084 | Ropinirole Hydrochloride | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [2]  6 6, 309 💬
 | 
| 1085 | Ropinirole hydrochloride extended-release tablet | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1086 | Ropinirole hydrochloride extended-release tablet placebo | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1087 | Ropinirole hydrochloride prolonged release | [2]  Manganese citrate Manganese citrate, Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1088 | Ropinirole immediate release | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1089 | Ropinirole Implant | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1090 | Ropinirole IR | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1091 | Ropinirole IR Tablets | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1092 | Ropinirole monotherapy | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1093 | Ropinirole oral product | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1094 | Ropinirole PR | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1095 | Ropinirole PR, 2mg | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1096 | Ropinirole PR/XR | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1097 | Ropinirole PR/XR Tablets | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1098 | Ropinirole Prolonged release | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1099 | Ropinirole prolonged release/extended release(PR/XR) | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1100 | Ropinirole XL | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1101 | Ropinirole XL (formerly CR) | [1]  Ropinirole Ropinirole | [1]  Ropinirole 
                
                    Ropinirole
                
             💬
 | [3]  DRD2 DRD2, DRD3, DRD4 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1102 | Ropinirole/L-dopa | [2]  Levodopa Levodopa, Ropinirole | [2]  Levodopa 
                
                    Levodopa
                
            , 
                
                    Ropinirole
                
             💬
 | [5]  DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
 | [11]  Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1103 | Ropivacaine | [1]  Ropivacaine Ropivacaine | [1]  Ropivacaine 
                
                    Ropivacaine
                
             💬
 | [5]  SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
 | [3]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [4]  22 22, 36, 46, 70 💬
 | 
| 1104 | Ropivacaine Hydrochloride Injection | [1]  Ropivacaine Ropivacaine | [1]  Ropivacaine 
                
                    Ropivacaine
                
             💬
 | [5]  SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
 | [3]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1]  70 70 💬
 | 
| 1105 | Ropivacaine plus normal saline | [1]  Ropivacaine Ropivacaine | [1]  Ropivacaine 
                
                    Ropivacaine
                
             💬
 | [5]  SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
 | [3]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1]  70 70 💬
 | 
| 1106 | Roscovitine | - | - | - | - | [1]  299 299 💬
 | 
| 1107 | Rosiglitazone | [1]  Rosiglitazone Rosiglitazone | [1]  Rosiglitazone 
                
                    Rosiglitazone
                
             💬
 | [1]  PPARG PPARG 💬
 | [11]  AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [5]  46 46, 75, 97, 222, 265 💬
 | 
| 1108 | Rosiglitazone (Avandia) | [1]  Rosiglitazone Rosiglitazone | [1]  Rosiglitazone 
                
                    Rosiglitazone
                
             💬
 | [1]  PPARG PPARG 💬
 | [11]  AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1]  222 222 💬
 | 
| 1109 | Rosiglitazone Extended Release Tablets | [1]  Rosiglitazone Rosiglitazone | [1]  Rosiglitazone 
                
                    Rosiglitazone
                
             💬
 | [1]  PPARG PPARG 💬
 | [11]  AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1]  46 46 💬
 | 
| 1110 | Rosiglitazone maleate | [1]  Rosiglitazone Rosiglitazone | [1]  Rosiglitazone 
                
                    Rosiglitazone
                
             💬
 | [1]  PPARG PPARG 💬
 | [11]  AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [3]  46 46, 75, 265 💬
 | 
| 1111 | Rosiglitazone XR | [1]  Rosiglitazone Rosiglitazone | [1]  Rosiglitazone 
                
                    Rosiglitazone
                
             💬
 | [1]  PPARG PPARG 💬
 | [11]  AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1]  46 46 💬
 | 
| 1112 | Rosuvastatin | [1]  Rosuvastatin Rosuvastatin | [1]  Rosuvastatin 
                
                    Rosuvastatin
                
             💬
 | [1]  HMGCR HMGCR 💬
 | [4]  AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [11]  6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬
 | 
| 1113 | Rosuvastatin 10 mg | [1]  Rosuvastatin Rosuvastatin | [1]  Rosuvastatin 
                
                    Rosuvastatin
                
             💬
 | [1]  HMGCR HMGCR 💬
 | [4]  AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1]  96 96 💬
 | 
| 1114 | Rosuvastatin 10mg | [1]  Rosuvastatin Rosuvastatin | [1]  Rosuvastatin 
                
                    Rosuvastatin
                
             💬
 | [1]  HMGCR HMGCR 💬
 | [4]  AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1]  97 97 💬
 | 
| 1115 | Rosuvastatin 20mg | [1]  Rosuvastatin Rosuvastatin | [1]  Rosuvastatin 
                
                    Rosuvastatin
                
             💬
 | [1]  HMGCR HMGCR 💬
 | [4]  AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1]  79 79 💬
 | 
| 1116 | ROSUVASTATIN CALCIUM | [2]  Calcium Calcium, Rosuvastatin | [1]  Rosuvastatin 
                
                    Rosuvastatin
                
             💬
 | [1]  HMGCR HMGCR 💬
 | [4]  AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [4]  49 49, 79, 97, 299 💬
 | 
| 1117 | Rosuvastatin calcium 40mg | [2]  Calcium Calcium, Rosuvastatin | [1]  Rosuvastatin 
                
                    Rosuvastatin
                
             💬
 | [1]  HMGCR HMGCR 💬
 | [4]  AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1]  56 56 💬
 | 
| 1118 | Rosuvastatine EG | - | - | - | - | [1]  97 97 💬
 | 
| 1119 | ROT-TDS 8 mg/24 h | - | - | - | - | [1]  6 6 💬
 | 
| 1120 | Rotigotin | - | - | - | - | [1]  6 6 💬
 | 
| 1121 | ROTIGOTINA | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1122 | ROTIGOTINE | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1123 | Rotigotine (Reference product PR 2.1.1) | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1124 | Rotigotine (Test product PR 2.3.1) | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1125 | Rotigotine hydrochloride | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1126 | Rotigotine Nasal Spray | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1127 | Rotigotine transdermal patch | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1128 | Rotigotine transdermal patch 2mg/24h(10cm2) | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1129 | Rotigotine transdermal patch 4mg/24h (20cm2) | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1130 | Rotigotine transdermal patch 6mg/24h (30cm2) | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1131 | Rotigotine transdermal patch 8mg/24h (40cm2) | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1132 | Rotigotine TTS (Test) | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1133 | Rotigotine, extended-release microspheres | [1]  Rotigotine Rotigotine | [1]  Rotigotine 
                
                    Rotigotine
                
             💬
 | [1]  DRD2 DRD2 💬
 | [8]  Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1]  6 6 💬
 | 
| 1134 | Routine steroid administration group | - | - | - | - | [1]  85 85 💬
 | 
| 1135 | Routine transdermal oestrogen patch | - | - | - | - | [1]  78 78 💬
 | 
| 1136 | Routine Treatment of CD | - | - | - | - | [1]  96 96 💬
 | 
| 1137 | Roxithromycin | [1]  Roxithromycin Roxithromycin | [1]  Roxithromycin 
                
                    Roxithromycin
                
             💬
 | - | - | [2]  46 46, 299 💬
 | 
| 1138 | Royal jelly | [1]  Royal jelly Royal jelly | [1]  Royal jelly 
                
                    Royal jelly
                
             💬
 | - | - | [1]  49 49 💬
 | 
| 1139 | ROZANOLIXIZUMAB | [1]  Rozanolixizumab Rozanolixizumab | [1]  Rozanolixizumab 
                
                    Rozanolixizumab
                
             💬
 | [1]  FCGRT FCGRT 💬
 | - | [3]  11 11, 14, 63 💬
 | 
| 1140 | ROZEREM | [1]  Ramelteon Ramelteon | [1]  Ramelteon 
                
                    Ramelteon
                
             💬
 | [2]  MTNR1A MTNR1A, MTNR1B 💬
 | [2]  Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1]  6 6 💬
 | 
| 1141 | Rozibafusp Alfa | - | - | - | - | [1]  49 49 💬
 | 
| 1142 | RP 103 | - | - | - | - | [2]  8 8, 19 💬
 | 
| 1143 | RP-A501 | - | - | - | - | [1]  32 32 💬
 | 
| 1144 | RP-L102 | - | - | - | - | [1]  285 285 💬
 | 
| 1145 | RP-L201 | - | - | - | - | [1]  65 65 💬
 | 
| 1146 | RP103 | - | - | - | - | [2]  8 8, 19 💬
 | 
| 1147 | RPC-1063 | - | - | - | - | [1]  13 13 💬
 | 
| 1148 | RPC0163 | - | - | - | - | [1]  96 96 💬
 | 
| 1149 | RPC1063 | - | - | - | - | [3]  13 13, 96, 97 💬
 | 
| 1150 | RPC1063 (equivalent to ozanimod | [1]  Ozanimod Ozanimod | [1]  Ozanimod 
                
                    Ozanimod
                
             💬
 | [5]  S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  96 96 💬
 | 
| 1151 | RPC1063 (equivalent to ozanimod HCl) | [1]  Ozanimod Ozanimod | [1]  Ozanimod 
                
                    Ozanimod
                
             💬
 | [5]  S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  96 96 💬
 | 
| 1152 | RPC1063 equiv to ozanimod HCI | [1]  Ozanimod Ozanimod | [1]  Ozanimod 
                
                    Ozanimod
                
             💬
 | [5]  S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  96 96 💬
 | 
| 1153 | RPC1063 equiv. to ozanimod HCI | [1]  Ozanimod Ozanimod | [1]  Ozanimod 
                
                    Ozanimod
                
             💬
 | [5]  S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
 | [3]  FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1]  96 96 💬
 | 
| 1154 | RPC4046 | - | - | - | - | [1]  98 98 💬
 | 
| 1155 | RPH-104 | - | - | - | - | [1]  266 266 💬
 | 
| 1156 | RPI78M for injection | - | - | - | - | [1]  20 20 💬
 | 
| 1157 | RPL554 | - | - | - | - | [1]  299 299 💬
 | 
| 1158 | RPS 2505 | - | - | - | - | [2]  246 246, 299 💬
 | 
| 1159 | RQ-00000010 | - | - | - | - | [1]  6 6 💬
 | 
| 1160 | RR110 (Tamibarotene) | [1]  Tamibarotene Tamibarotene | [1]  Tamibarotene 
                
                    Tamibarotene
                
             💬
 | [1]  RARA RARA 💬
 | [5]  Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [1]  96 96 💬
 | 
| 1161 | RS-BACLOFEN | [1]  Baclofen Baclofen | [1]  Baclofen 
                
                    Baclofen
                
             💬
 | [2]  GABBR1 GABBR1, GABBR2 💬
 | [7]  Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1]  10 10 💬
 | 
| 1162 | RSLV-132 | - | - | - | - | [2]  49 49, 53 💬
 | 
| 1163 | RST-001 | - | - | - | - | [1]  90 90 💬
 | 
| 1164 | RT001 | - | - | - | - | [3]  2 2, 5, 120 💬
 | 
| 1165 | RT234 - vardenafil inhalation powder | [1]  Vardenafil Vardenafil | [1]  Vardenafil 
                
                    Vardenafil
                
             💬
 | [1]  PDE5A PDE5A 💬
 | [3]  Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1]  86 86 💬
 | 
| 1166 | RTA 402 | - | - | - | - | [3]  67 67, 86, 218 💬
 | 
| 1167 | RTL1000 (recombinant T cell receptor ligand) | - | - | - | - | [1]  13 13 💬
 | 
| 1168 | RTNV148B IgG | - | - | - | - | [3]  46 46, 97, 271 💬
 | 
| 1169 | RTV | - | - | - | - | [1]  265 265 💬
 | 
| 1170 | RTX | - | - | - | - | [5]  11 11, 46, 65, 222, 240 💬
 | 
| 1171 | RTX-134 | - | - | - | - | [1]  240 240 💬
 | 
| 1172 | Rubidium | [1]  Rubidium Rubidium | - | - | - | [1]  84 84 💬
 | 
| 1173 | RUFINAMIDE | [1]  Rufinamide Rufinamide | [1]  Rufinamide 
                
                    Rufinamide
                
             💬
 | [5]  SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
 | [3]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1]  144 144 💬
 | 
| 1174 | Rufinamide (E2080) | [1]  Rufinamide Rufinamide | [1]  Rufinamide 
                
                    Rufinamide
                
             💬
 | [5]  SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
 | [3]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1]  144 144 💬
 | 
| 1175 | Rufinamide oral suspension | [1]  Rufinamide Rufinamide | [1]  Rufinamide 
                
                    Rufinamide
                
             💬
 | [5]  SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
 | [3]  Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1]  144 144 💬
 | 
| 1176 | Rupatadine | [1]  Rupatadine Rupatadine | [1]  Rupatadine 
                
                    Rupatadine
                
             💬
 | [2]  HRH1 HRH1, PTAFR 💬
 | [4]  Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | [1]  46 46 💬
 | 
| 1177 | Rurioctocog alfa pegol | [1]  Rurioctocog alfa pegol Rurioctocog alfa pegol | [1]  Rurioctocog alfa pegol 
                
                    Rurioctocog alfa pegol
                
             💬
 | - | - | [1]  288 288 💬
 | 
| 1178 | Ruxience | [1]  Rituximab Rituximab | [1]  Rituximab 
                
                    Rituximab
                
             💬
 | [1]  MS4A1 MS4A1 💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1]  13 13 💬
 | 
| 1179 | Ruxolitinib | [1]  Ruxolitinib Ruxolitinib | [1]  Ruxolitinib 
                
                    Ruxolitinib
                
             💬
 | [2]  JAK1 JAK1, JAK2 💬
 | [35]  AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [3]  60 60, 65, 228 💬
 | 
| 1180 | RVA576 | - | - | - | - | [3]  62 62, 109, 162 💬
 | 
| 1181 | RVA576 (COVERSIN) | [1]  Nomacopan Nomacopan | [1]  Nomacopan 
                
                    Nomacopan
                
             💬
 | [1]  C5 C5 💬
 | [11]  Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [2]  62 62, 109 💬
 | 
| 1182 | RVG 03820 | - | - | - | - | [1]  3 3 💬
 | 
| 1183 | RVG 05565 | - | - | - | - | [1]  96 96 💬
 | 
| 1184 | RVG 07151 | - | - | - | - | [1]  96 96 💬
 | 
| 1185 | RVG 08740 | - | - | - | - | [1]  6 6 💬
 | 
| 1186 | RVG 08938 | - | - | - | - | [1]  75 75 💬
 | 
| 1187 | RVG 101614 | - | - | - | - | [1]  60 60 💬
 | 
| 1188 | RVG 104433 | - | - | - | - | [1]  107 107 💬
 | 
| 1189 | RVG 105155 | - | - | - | - | [1]  60 60 💬
 | 
| 1190 | RVG 114681 | - | - | - | - | [1]  96 96 💬
 | 
| 1191 | RVG 116648 | - | - | - | - | [1]  96 96 💬
 | 
| 1192 | RVG 13760 | - | - | - | - | [1]  298 298 💬
 | 
| 1193 | RVG 15375 | - | - | - | - | [1]  75 75 💬
 | 
| 1194 | RVG 15790 or RVG 25480 | - | - | - | - | [1]  78 78 💬
 | 
| 1195 | RVG 18236 | - | - | - | - | [2]  75 75, 227 💬
 | 
| 1196 | RVG 18388 | - | - | - | - | [1]  160 160 💬
 | 
| 1197 | RVG 28636 | - | - | - | - | [1]  107 107 💬
 | 
| 1198 | RVG 33865 | - | - | - | - | [1]  86 86 💬
 | 
| 1199 | RVG 51680 | - | - | - | - | [1]  14 14 💬
 | 
| 1200 | RVG 55618 | - | - | - | - | [1]  6 6 💬
 | 
| 1201 | RVG 56083 | - | - | - | - | [1]  14 14 💬
 | 
| 1202 | RVG00859 | - | - | - | - | [1]  96 96 💬
 | 
| 1203 | RVT-101 35 mg | - | - | - | - | [1]  6 6 💬
 | 
| 1204 | RVT-1201 | - | - | - | - | [1]  86 86 💬
 | 
| 1205 | RVT-1401 | - | - | - | - | [2]  11 11, 61 💬
 | 
| 1206 | RVT-1601 | - | - | - | - | [1]  85 85 💬
 | 
| 1207 | RVT-1601 (formerly, PA101B) | - | - | - | - | [1]  85 85 💬
 | 
| 1208 | RVT-1601 (in precedenza PA101B) | - | - | - | - | [1]  85 85 💬
 | 
| 1209 | RVWF | - | - | - | - | [1]  288 288 💬
 | 
| 1210 | RVX000222 | - | - | - | - | [1]  19 19 💬
 | 
| 1211 | RWJ-445380 100 mg | - | - | - | - | [1]  46 46 💬
 | 
| 1212 | RWJ-445380 200 mg | - | - | - | - | [1]  46 46 💬
 | 
| 1213 | RWJ-445380 300 mg | - | - | - | - | [1]  46 46 💬
 | 
| 1214 | RWJ-445380 capsule 100 mg | - | - | - | - | [1]  46 46 💬
 | 
| 1215 | RWJ-445380 capsules 150 mg | - | - | - | - | [1]  46 46 💬
 | 
| 1216 | RWJ-445380 Capsules 50 mg | - | - | - | - | [1]  46 46 💬
 | 
| 1217 | RWJ-445380-002 | - | - | - | - | [1]  46 46 💬
 | 
| 1218 | RXC007 | - | - | - | - | [1]  85 85 💬
 | 
| 1219 | RYR | - | - | - | - | [1]  46 46 💬
 | 
| 1220 | Rytary 145 mg | - | - | - | - | [1]  6 6 💬
 | 
| 1221 | Rytary 195 mg | - | - | - | - | [1]  6 6 💬
 | 
| 1222 | Répaglinide | - | - | - | - | [1]  299 299 💬
 |